Fishingboy personal page - To The Moon

Fishingboy

Fishingboy

No personal profile

17Follow

2Followers

0Topic

0Badge

2021-08-05

$Bitfarms Ltd.(BITF)$Set the wrong buy limit but I guess 10% profit is still better than nothing

2021-06-25

Good to think about it!

Sorry, the original content has been removed

2021-06-25

That’s good news

Sorry, the original content has been removed

2021-06-24

$SEA LTD(SE)$Not sure about you but I see a W pattern on the daily with an upside target of around usd400. Might dip back to the usd200++ level if it fails.Sea Group looking bullish but they should lookto sustain growth.Not here to predict but to prepare.*my opinion, never financial advice*

2021-03-16

Go cathie!!

Sorry, the original content has been removed

2021-03-16

Please be safe!

Germany, Italy, France suspend AstraZeneca shots amid safety fears, disrupting EU vaccinations

2021-03-15

Appreciate posts like this that end up on Tiger’s news page. It helps us do due diligence easily

10 Stocks That Are Vulnerable to a Blowup

2021-03-15

Indeed this will be interesting to watch!

Sorry, the original content has been removed

2021-03-12

Yes indeed that is true

Sorry, the original content has been removed

2021-03-11

$Sea Ltd(SE)$Was a little disappointed that we didn’t hold the slope up yesterday but I guess it would be good to spend more time in consolidation mode. It could be difficult to see but will be healthier in the long run. Hoping for more sustained upside action in the months to come!

2021-03-10

$AYRO, Inc.(AYRO)$Lol

2021-03-10

Must be careful

Sorry, the original content has been removed

2021-03-10

This is good news but I hope it sustains the bounce

Sorry, the original content has been removed

2021-03-10

It can bounce but I hope it maintains the bounce

Sorry, the original content has been removed

2021-03-09

$Sea Ltd(SE)$My only regret is not buying when Shopee launched in Singapore a few years ago. They’re actually doing quite well in terms of public sentiment and I think they’ll do well compared to direct competitors

2021-03-09

Go J&J!

J&J 'under stress' to meet EU second-quarter vaccine supply goal - source

2021-03-07

Oh no

Palantir plunged more than 13%

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3578051801807213","uuid":"3578051801807213","gmtCreate":1614957777979,"gmtModify":1615127155737,"name":"Fishingboy","pinyin":"fishingboy","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":17,"tweetSize":17,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.07","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":2,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":899885493,"gmtCreate":1628173737712,"gmtModify":1703502597837,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BITF\">$Bitfarms Ltd.(BITF)$</a>Set the wrong buy limit but I guess 10% profit is still better than nothing&nbsp;","listText":"<a href=\"https://laohu8.com/S/BITF\">$Bitfarms Ltd.(BITF)$</a>Set the wrong buy limit but I guess 10% profit is still better than nothing&nbsp;","text":"$Bitfarms Ltd.(BITF)$Set the wrong buy limit but I guess 10% profit is still better than nothing","images":[{"img":"https://static.tigerbbs.com/803c9b4ab887314e0ebb7722c4770c51","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899885493","isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125013748,"gmtCreate":1624636375684,"gmtModify":1703842504505,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Good to think about it!","listText":"Good to think about it!","text":"Good to think about it!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/125013748","repostId":"2146079086","repostType":4,"isVote":1,"tweetType":1,"viewCount":273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126867391,"gmtCreate":1624551772513,"gmtModify":1703840275896,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"That’s good news","listText":"That’s good news","text":"That’s good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/126867391","repostId":"2145704596","repostType":4,"isVote":1,"tweetType":1,"viewCount":158,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126800775,"gmtCreate":1624549531097,"gmtModify":1703840196606,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SE\">$SEA LTD(SE)$</a>Not sure about you but I see a W pattern on the daily with an upside target of around usd400. Might dip back to the usd200++ level if it fails.Sea Group looking bullish but they should lookto&nbsp;sustain&nbsp;growth.Not here to predict but to prepare.*my opinion, never financial advice*","listText":"<a href=\"https://laohu8.com/S/SE\">$SEA LTD(SE)$</a>Not sure about you but I see a W pattern on the daily with an upside target of around usd400. Might dip back to the usd200++ level if it fails.Sea Group looking bullish but they should lookto&nbsp;sustain&nbsp;growth.Not here to predict but to prepare.*my opinion, never financial advice*","text":"$SEA LTD(SE)$Not sure about you but I see a W pattern on the daily with an upside target of around usd400. Might dip back to the usd200++ level if it fails.Sea Group looking bullish but they should lookto sustain growth.Not here to predict but to prepare.*my opinion, never financial advice*","images":[{"img":"https://static.tigerbbs.com/d3e90c1fec4c1674412f816421694e72","width":"1170","height":"2532"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/126800775","isVote":1,"tweetType":1,"viewCount":1406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},{"id":325047787,"gmtCreate":1615854124149,"gmtModify":1704787441210,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Go cathie!!","listText":"Go cathie!!","text":"Go cathie!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325047787","repostId":"1170973847","repostType":4,"isVote":1,"tweetType":1,"viewCount":212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":325047668,"gmtCreate":1615854105854,"gmtModify":1704787441371,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Please be safe!","listText":"Please be safe!","text":"Please be safe!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325047668","repostId":"1145894014","repostType":4,"repost":{"id":"1145894014","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1615845475,"share":"https://ttm.financial/m/news/1145894014?lang=&edition=fundamental","pubTime":"2021-03-16 05:57","market":"us","language":"en","title":"Germany, Italy, France suspend AstraZeneca shots amid safety fears, disrupting EU vaccinations","url":"https://stock-news.laohu8.com/highlight/detail?id=1145894014","media":"Reuters","summary":"Germany, France and Italy said on Monday they would suspend AstraZeneca COVID-19 shots after several","content":"<p>Germany, France and Italy said on Monday they would suspend AstraZeneca COVID-19 shots after several countries reported possible serious side-effects, but the World Health Organization&nbsp;(WHO) said there was no proven link and people should not panic.</p>\n<p>Still, the decision by the European Union’s three biggest countries to put inoculations with the AstraZeneca shot on hold threw the already struggling vaccination campaign in the 27-nation EU into disarray.</p>\n<p>Denmark and Norway stopped giving the shot last week after reporting isolated cases of bleeding, blood clots and a low platelet count. Iceland and Bulgaria followed suit and Ireland and the Netherlands announced suspensions on Sunday.</p>\n<p>Spain will stop using the vaccine for at least 15 days, Cadena Ser radio reported, citing unnamed sources.</p>\n<p>The top WHO scientist reiterated on Monday that there have been no documented deaths linked to COVID-19 vaccines.</p>\n<p>“We do not want people to panic,” Soumya Swaminathan said on a virtual media briefing, adding there has been no association, so far, pinpointed between so-called “thromboembolic events” reported in some countries and COVID-19 shots.</p>\n<p>WHO chief Tedros Adhanom Ghebreyesus said an advisory committee meeting on AstraZeneca would be held on Tuesday. EU medicines regulator EMA will also convene this week to assess the information gathered into whether the AstraZeneca shot contributed to thromboembolic events in those inoculated.</p>\n<p>The moves by some of Europe’s largest and most populous countries will deepen concerns about the slow rollout of vaccines in the region, which has been plagued by shortages due to problems producing vaccines, including AstraZeneca’s.</p>\n<p>Germany warned last week it was facing a third wave of infections, Italy is intensifying lockdowns and hospitals in the Paris region are close to being overloaded.</p>\n<p>German Health Minister Jens Spahn said that although the risk of blood clots was low, it could not be ruled out.</p>\n<p>“This is a professional decision, not a political one,” Spahn said, adding he was following a recommendation of the Paul Ehrlich Institute, Germany’s vaccine regulator.</p>\n<p>France said it was suspending the vaccine’s use pending an assessment by EMA.</p>\n<p>“The decision taken, in conformity also with our European policy, is to suspend, out of precaution, vaccination with the AZ shot, hoping that we can resume quickly if the EMA’s guidance allows,” French President Emmanuel Macron said.</p>\n<p>Italy said its halt was a “precautionary and temporary measure” pending EMA’s ruling.</p>\n<p>“The EMA will meet soon to clarify any doubts so that the AstraZeneca vaccine can be resumed safely in the vaccination campaign as soon as possible,” said Gianni Rezza, Director General of Prevention at Italy’s Ministry of Health.</p>\n<p>Austria and Spain have stopped using particular batches and prosecutors in the northern Italian region of Piedmont earlier seized 393,600 doses following the death of a man hours after he was vaccinated. It was the second region to do so after Sicily, where two people had died shortly after having their shots.</p>\n<p>The WHO appealed to countries not to suspend vaccinations against a disease that has caused more than 2.7 million deaths worldwide. WHO Director-General Tedros said systems were in place to protect public health.</p>\n<p>“This does not necessarily mean these events are linked to COVID-19 vaccination, but it’s routine practice to investigate them, and it shows that the surveillance system works and that effective controls are in place,” he told the media briefing.</p>\n<p>The United Kingdom said it had no concerns, while Poland said it thought the benefits outweighed any risks.</p>\n<p>The EMA has said that as of March 10, a total of 30 cases of blood clotting had been reported among close to 5 million people vaccinated with the AstraZeneca shot in the European Economic Area, which links 30 European countries.</p>\n<p>Michael Head, a senior research fellow in global health at the University of Southampton, said the decisions by France, Germany and others looked baffling.</p>\n<p>“The data we have suggests that numbers of adverse events related to blood clots are the same (and possibly, in fact lower) in vaccinated groups compared to unvaccinated populations,” he said, adding that halting a vaccination programme had consequences.</p>\n<p>“This results in delays in protecting people, and the potential for increased vaccine hesitancy, as a result of people who have seen the headlines and understandably become concerned. There are no signs yet of any data that really justify these decisions.”</p>\n<p>A senior German infectious diseases physician, however, said the background incidence of 2-5 thromboses per million per year was significantly lower than the number of 7 out of 1.6 million vaccinated people cited by Germany’s health ministry.</p>\n<p>“This should be the reason to suspend the vaccination in Germany until all cases, including suspected cases in Germany and Europe, have been completely cleared up,” said Clemens Wendtner, head of the special unit for highly contagious life threatening infections at the Schwabing Clinic in Munich.</p>\n<p><b>‘UNUSUAL’ SYMPTOMS</b></p>\n<p>AstraZeneca’s shot was among the first and cheapest to be developed and launched at volume since the coronavirus was first identified in central China at the end of 2019, and is set to be the mainstay of vaccination programmes in much of the developing world.</p>\n<p>Thailand announced plans on Monday to go ahead with the Anglo-Swedish firm’s shot after suspending its use on Friday, but Indonesia said it would wait for the WHO to report.</p>\n<p>The WHO said its advisory panel was reviewing reports related to the shot and would release its findings as soon as possible. But it said it was unlikely to change its recommendations, issued last month, for widespread use, including in countries where the South African variant of the virus may reduce its efficacy.</p>\n<p>The EMA has also said there was no indication the events were caused by the vaccination and that the number of reported blood clots was no higher than seen in the general population.</p>\n<p>But the handful of reported side-effects in Europe have upset vaccination programmes already stumbling over slow rollouts and vaccine scepticism in some countries.</p>\n<p>The Netherlands said on Monday it had seen 10 cases of possible noteworthy adverse side-effects from the AstraZeneca shot, hours after putting its vaccination programme on hold following reports of potential side-effects in other countries.</p>\n<p>Recent information indicates “a very special, rarely occurring form of thrombosis, of which some cases appear to have occurred shortly after vaccination. This is of course suspicious and should be investigated,” said Anke Huckriede, vaccinology professor at the University of Groningen in the Netherlands.</p>\n<p>Denmark reported “highly unusual” symptoms in a 60-year-old citizen who died from a blood clot after receiving the vaccine, the same phrase used on Saturday by Norway about three people under the age of 50 it said were being treated in hospital.</p>\n<p>One of the three health workers hospitalised in Norway after receiving the AstraZeneca shot had died, health authorities said on Monday, but there was no evidence the vaccine was the cause.</p>\n<p>AstraZeneca said earlier it had conducted a review covering more than 17 million people vaccinated in the EU and the UK which had shown no evidence of an increased risk of blood clots.</p>\n<p>Long-awaited results from AstraZeneca’s 30,000-person U.S. vaccine trial are now being reviewed by independent monitors to determine whether the shot is safe and effective, a top U.S. official said on Monday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Germany, Italy, France suspend AstraZeneca shots amid safety fears, disrupting EU vaccinations</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGermany, Italy, France suspend AstraZeneca shots amid safety fears, disrupting EU vaccinations\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-16 05:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Germany, France and Italy said on Monday they would suspend AstraZeneca COVID-19 shots after several countries reported possible serious side-effects, but the World Health Organization&nbsp;(WHO) said there was no proven link and people should not panic.</p>\n<p>Still, the decision by the European Union’s three biggest countries to put inoculations with the AstraZeneca shot on hold threw the already struggling vaccination campaign in the 27-nation EU into disarray.</p>\n<p>Denmark and Norway stopped giving the shot last week after reporting isolated cases of bleeding, blood clots and a low platelet count. Iceland and Bulgaria followed suit and Ireland and the Netherlands announced suspensions on Sunday.</p>\n<p>Spain will stop using the vaccine for at least 15 days, Cadena Ser radio reported, citing unnamed sources.</p>\n<p>The top WHO scientist reiterated on Monday that there have been no documented deaths linked to COVID-19 vaccines.</p>\n<p>“We do not want people to panic,” Soumya Swaminathan said on a virtual media briefing, adding there has been no association, so far, pinpointed between so-called “thromboembolic events” reported in some countries and COVID-19 shots.</p>\n<p>WHO chief Tedros Adhanom Ghebreyesus said an advisory committee meeting on AstraZeneca would be held on Tuesday. EU medicines regulator EMA will also convene this week to assess the information gathered into whether the AstraZeneca shot contributed to thromboembolic events in those inoculated.</p>\n<p>The moves by some of Europe’s largest and most populous countries will deepen concerns about the slow rollout of vaccines in the region, which has been plagued by shortages due to problems producing vaccines, including AstraZeneca’s.</p>\n<p>Germany warned last week it was facing a third wave of infections, Italy is intensifying lockdowns and hospitals in the Paris region are close to being overloaded.</p>\n<p>German Health Minister Jens Spahn said that although the risk of blood clots was low, it could not be ruled out.</p>\n<p>“This is a professional decision, not a political one,” Spahn said, adding he was following a recommendation of the Paul Ehrlich Institute, Germany’s vaccine regulator.</p>\n<p>France said it was suspending the vaccine’s use pending an assessment by EMA.</p>\n<p>“The decision taken, in conformity also with our European policy, is to suspend, out of precaution, vaccination with the AZ shot, hoping that we can resume quickly if the EMA’s guidance allows,” French President Emmanuel Macron said.</p>\n<p>Italy said its halt was a “precautionary and temporary measure” pending EMA’s ruling.</p>\n<p>“The EMA will meet soon to clarify any doubts so that the AstraZeneca vaccine can be resumed safely in the vaccination campaign as soon as possible,” said Gianni Rezza, Director General of Prevention at Italy’s Ministry of Health.</p>\n<p>Austria and Spain have stopped using particular batches and prosecutors in the northern Italian region of Piedmont earlier seized 393,600 doses following the death of a man hours after he was vaccinated. It was the second region to do so after Sicily, where two people had died shortly after having their shots.</p>\n<p>The WHO appealed to countries not to suspend vaccinations against a disease that has caused more than 2.7 million deaths worldwide. WHO Director-General Tedros said systems were in place to protect public health.</p>\n<p>“This does not necessarily mean these events are linked to COVID-19 vaccination, but it’s routine practice to investigate them, and it shows that the surveillance system works and that effective controls are in place,” he told the media briefing.</p>\n<p>The United Kingdom said it had no concerns, while Poland said it thought the benefits outweighed any risks.</p>\n<p>The EMA has said that as of March 10, a total of 30 cases of blood clotting had been reported among close to 5 million people vaccinated with the AstraZeneca shot in the European Economic Area, which links 30 European countries.</p>\n<p>Michael Head, a senior research fellow in global health at the University of Southampton, said the decisions by France, Germany and others looked baffling.</p>\n<p>“The data we have suggests that numbers of adverse events related to blood clots are the same (and possibly, in fact lower) in vaccinated groups compared to unvaccinated populations,” he said, adding that halting a vaccination programme had consequences.</p>\n<p>“This results in delays in protecting people, and the potential for increased vaccine hesitancy, as a result of people who have seen the headlines and understandably become concerned. There are no signs yet of any data that really justify these decisions.”</p>\n<p>A senior German infectious diseases physician, however, said the background incidence of 2-5 thromboses per million per year was significantly lower than the number of 7 out of 1.6 million vaccinated people cited by Germany’s health ministry.</p>\n<p>“This should be the reason to suspend the vaccination in Germany until all cases, including suspected cases in Germany and Europe, have been completely cleared up,” said Clemens Wendtner, head of the special unit for highly contagious life threatening infections at the Schwabing Clinic in Munich.</p>\n<p><b>‘UNUSUAL’ SYMPTOMS</b></p>\n<p>AstraZeneca’s shot was among the first and cheapest to be developed and launched at volume since the coronavirus was first identified in central China at the end of 2019, and is set to be the mainstay of vaccination programmes in much of the developing world.</p>\n<p>Thailand announced plans on Monday to go ahead with the Anglo-Swedish firm’s shot after suspending its use on Friday, but Indonesia said it would wait for the WHO to report.</p>\n<p>The WHO said its advisory panel was reviewing reports related to the shot and would release its findings as soon as possible. But it said it was unlikely to change its recommendations, issued last month, for widespread use, including in countries where the South African variant of the virus may reduce its efficacy.</p>\n<p>The EMA has also said there was no indication the events were caused by the vaccination and that the number of reported blood clots was no higher than seen in the general population.</p>\n<p>But the handful of reported side-effects in Europe have upset vaccination programmes already stumbling over slow rollouts and vaccine scepticism in some countries.</p>\n<p>The Netherlands said on Monday it had seen 10 cases of possible noteworthy adverse side-effects from the AstraZeneca shot, hours after putting its vaccination programme on hold following reports of potential side-effects in other countries.</p>\n<p>Recent information indicates “a very special, rarely occurring form of thrombosis, of which some cases appear to have occurred shortly after vaccination. This is of course suspicious and should be investigated,” said Anke Huckriede, vaccinology professor at the University of Groningen in the Netherlands.</p>\n<p>Denmark reported “highly unusual” symptoms in a 60-year-old citizen who died from a blood clot after receiving the vaccine, the same phrase used on Saturday by Norway about three people under the age of 50 it said were being treated in hospital.</p>\n<p>One of the three health workers hospitalised in Norway after receiving the AstraZeneca shot had died, health authorities said on Monday, but there was no evidence the vaccine was the cause.</p>\n<p>AstraZeneca said earlier it had conducted a review covering more than 17 million people vaccinated in the EU and the UK which had shown no evidence of an increased risk of blood clots.</p>\n<p>Long-awaited results from AstraZeneca’s 30,000-person U.S. vaccine trial are now being reviewed by independent monitors to determine whether the shot is safe and effective, a top U.S. official said on Monday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AZN.UK":"阿斯利康制药","AZN":"阿斯利康"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1145894014","content_text":"Germany, France and Italy said on Monday they would suspend AstraZeneca COVID-19 shots after several countries reported possible serious side-effects, but the World Health Organization (WHO) said there was no proven link and people should not panic.\nStill, the decision by the European Union’s three biggest countries to put inoculations with the AstraZeneca shot on hold threw the already struggling vaccination campaign in the 27-nation EU into disarray.\nDenmark and Norway stopped giving the shot last week after reporting isolated cases of bleeding, blood clots and a low platelet count. Iceland and Bulgaria followed suit and Ireland and the Netherlands announced suspensions on Sunday.\nSpain will stop using the vaccine for at least 15 days, Cadena Ser radio reported, citing unnamed sources.\nThe top WHO scientist reiterated on Monday that there have been no documented deaths linked to COVID-19 vaccines.\n“We do not want people to panic,” Soumya Swaminathan said on a virtual media briefing, adding there has been no association, so far, pinpointed between so-called “thromboembolic events” reported in some countries and COVID-19 shots.\nWHO chief Tedros Adhanom Ghebreyesus said an advisory committee meeting on AstraZeneca would be held on Tuesday. EU medicines regulator EMA will also convene this week to assess the information gathered into whether the AstraZeneca shot contributed to thromboembolic events in those inoculated.\nThe moves by some of Europe’s largest and most populous countries will deepen concerns about the slow rollout of vaccines in the region, which has been plagued by shortages due to problems producing vaccines, including AstraZeneca’s.\nGermany warned last week it was facing a third wave of infections, Italy is intensifying lockdowns and hospitals in the Paris region are close to being overloaded.\nGerman Health Minister Jens Spahn said that although the risk of blood clots was low, it could not be ruled out.\n“This is a professional decision, not a political one,” Spahn said, adding he was following a recommendation of the Paul Ehrlich Institute, Germany’s vaccine regulator.\nFrance said it was suspending the vaccine’s use pending an assessment by EMA.\n“The decision taken, in conformity also with our European policy, is to suspend, out of precaution, vaccination with the AZ shot, hoping that we can resume quickly if the EMA’s guidance allows,” French President Emmanuel Macron said.\nItaly said its halt was a “precautionary and temporary measure” pending EMA’s ruling.\n“The EMA will meet soon to clarify any doubts so that the AstraZeneca vaccine can be resumed safely in the vaccination campaign as soon as possible,” said Gianni Rezza, Director General of Prevention at Italy’s Ministry of Health.\nAustria and Spain have stopped using particular batches and prosecutors in the northern Italian region of Piedmont earlier seized 393,600 doses following the death of a man hours after he was vaccinated. It was the second region to do so after Sicily, where two people had died shortly after having their shots.\nThe WHO appealed to countries not to suspend vaccinations against a disease that has caused more than 2.7 million deaths worldwide. WHO Director-General Tedros said systems were in place to protect public health.\n“This does not necessarily mean these events are linked to COVID-19 vaccination, but it’s routine practice to investigate them, and it shows that the surveillance system works and that effective controls are in place,” he told the media briefing.\nThe United Kingdom said it had no concerns, while Poland said it thought the benefits outweighed any risks.\nThe EMA has said that as of March 10, a total of 30 cases of blood clotting had been reported among close to 5 million people vaccinated with the AstraZeneca shot in the European Economic Area, which links 30 European countries.\nMichael Head, a senior research fellow in global health at the University of Southampton, said the decisions by France, Germany and others looked baffling.\n“The data we have suggests that numbers of adverse events related to blood clots are the same (and possibly, in fact lower) in vaccinated groups compared to unvaccinated populations,” he said, adding that halting a vaccination programme had consequences.\n“This results in delays in protecting people, and the potential for increased vaccine hesitancy, as a result of people who have seen the headlines and understandably become concerned. There are no signs yet of any data that really justify these decisions.”\nA senior German infectious diseases physician, however, said the background incidence of 2-5 thromboses per million per year was significantly lower than the number of 7 out of 1.6 million vaccinated people cited by Germany’s health ministry.\n“This should be the reason to suspend the vaccination in Germany until all cases, including suspected cases in Germany and Europe, have been completely cleared up,” said Clemens Wendtner, head of the special unit for highly contagious life threatening infections at the Schwabing Clinic in Munich.\n‘UNUSUAL’ SYMPTOMS\nAstraZeneca’s shot was among the first and cheapest to be developed and launched at volume since the coronavirus was first identified in central China at the end of 2019, and is set to be the mainstay of vaccination programmes in much of the developing world.\nThailand announced plans on Monday to go ahead with the Anglo-Swedish firm’s shot after suspending its use on Friday, but Indonesia said it would wait for the WHO to report.\nThe WHO said its advisory panel was reviewing reports related to the shot and would release its findings as soon as possible. But it said it was unlikely to change its recommendations, issued last month, for widespread use, including in countries where the South African variant of the virus may reduce its efficacy.\nThe EMA has also said there was no indication the events were caused by the vaccination and that the number of reported blood clots was no higher than seen in the general population.\nBut the handful of reported side-effects in Europe have upset vaccination programmes already stumbling over slow rollouts and vaccine scepticism in some countries.\nThe Netherlands said on Monday it had seen 10 cases of possible noteworthy adverse side-effects from the AstraZeneca shot, hours after putting its vaccination programme on hold following reports of potential side-effects in other countries.\nRecent information indicates “a very special, rarely occurring form of thrombosis, of which some cases appear to have occurred shortly after vaccination. This is of course suspicious and should be investigated,” said Anke Huckriede, vaccinology professor at the University of Groningen in the Netherlands.\nDenmark reported “highly unusual” symptoms in a 60-year-old citizen who died from a blood clot after receiving the vaccine, the same phrase used on Saturday by Norway about three people under the age of 50 it said were being treated in hospital.\nOne of the three health workers hospitalised in Norway after receiving the AstraZeneca shot had died, health authorities said on Monday, but there was no evidence the vaccine was the cause.\nAstraZeneca said earlier it had conducted a review covering more than 17 million people vaccinated in the EU and the UK which had shown no evidence of an increased risk of blood clots.\nLong-awaited results from AstraZeneca’s 30,000-person U.S. vaccine trial are now being reviewed by independent monitors to determine whether the shot is safe and effective, a top U.S. official said on Monday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":322670070,"gmtCreate":1615806244890,"gmtModify":1704786767884,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Appreciate posts like this that end up on Tiger’s news page. It helps us do due diligence easily&nbsp;","listText":"Appreciate posts like this that end up on Tiger’s news page. It helps us do due diligence easily&nbsp;","text":"Appreciate posts like this that end up on Tiger’s news page. It helps us do due diligence easily","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322670070","repostId":"1164885443","repostType":4,"repost":{"id":"1164885443","pubTimestamp":1615805768,"share":"https://ttm.financial/m/news/1164885443?lang=&edition=fundamental","pubTime":"2021-03-15 18:56","market":"us","language":"en","title":"10 Stocks That Are Vulnerable to a Blowup","url":"https://stock-news.laohu8.com/highlight/detail?id=1164885443","media":"Barrons","summary":"Avoiding stock blowups is in every investor’s interest, but it’s getting a bit tougher.Many companie","content":"<p>Avoiding stock blowups is in every investor’s interest, but it’s getting a bit tougher.</p><p>Many companies that beat fourth-quarter estimates haven’t been rewarded with higher share prices. High-growth stocks are facing steeper hurdles from rising bond yields. Investors appear to be rotating from growth to value and into sectors with more exposure to a cyclical economic recovery.</p><p>Quite simply, fatigue may be setting into overcrowded trades and investment themes—whether those are alternative-meat producers, a travel recovery, green energy, or the continued domination of Big Tech.</p><p>Against that backdrop, investors may want to tread cautiously. One way to do so: Avoid stocks with low earnings quality and high short interest—meaning there are short positions, or bearish bets, on a large percentage of a company’s shares outstanding. (A short position is when investors borrow and then sell shares, betting that a stock’s price will fall so they can buy shares back at a cheaper price.) Stocks with that combination of attributes may be most at risk of underperforming or blowing up, according to Wolfe Research.</p><p>The firm ranks stocks on a relative basis within sectors by scoring earnings quality on seven financial measures, while also looking at valuation and sentiment indicators, based on fourth-quarter financials.</p><p>Wolfe calls stocks scoring in the bottom 10% of earnings quality, while also seeing high short interest, “our highest conviction cohort of stocks to avoid.”</p><p>One caveat: Low-quality stocks have been a popular trade—fueled by ample market liquidity and demand for riskier assets. High short interest also primes a stock for a short-squeeze, whereby traders who are short buy the stock to cover their positions, exerting upward pressure on the price. Nothing illustrates that dynamic more than the frenzied trading around GameStop (ticker: GME) this year.</p><p>Beauty products maker Coty (COTY), for example, shows up on Wolfe’s screen. But it may have already had its blowup, falling 15% the day it released its earnings report in February. Barron’s was bullish on the stock in the aftermath, and it has been moving up since then.</p><p>Nonetheless, plenty of other stocks on Wolfe’s watch list do seem vulnerable. Many have surged in a reopening trade or company-specific dynamics, and all trade at steep valuations. Here are 10 stocks from Wolfe’s list:</p><p>Carvana (CVNA), for instance, has been a blockbuster, gaining 535% over the last 52 weeks. Investors appear to have decided that it is a disruptive force in car buying and that a pandemic-fueled shift to online sales has accelerated its momentum. However, Carvana isn’t close to reporting a profit, and is expected to lose $1.96 a share this year and 97 cents in 2022.</p><p>The stock is up around 11% this year, but it has been wobbling lately and is down from its 52-week high around $315, trading recently at $287. Short interest is high at 22% of the shares outstanding, according to FactSet.</p><p>Expedia Group (EXPE) has surged 32% this year. Investors expect online bookings volume to soar as consumers head for vacations this summer and fall. Wall Street doesn’t see Expedia Group earning a profit this year but expects big gains in 2022 with earnings per share of $6.04. At recent prices around $175, shares trade at 28 times 2022 earnings, a 40% premium to the S&amp;P 500 ‘s multiple of 20 times.</p><p>Norwegian Cruise Line Holdings (NCLH) is also trading on hopes for a travel rebound in 2022. Wall Street expects revenues of $1.6 billion this year, up from $1.3 billion in 2020. But the stock is riding on expectations of a surge to $6 billion in revenue in 2022. Analysts are looking for earnings of 62 cents a share in 2022, up from an expected loss of $5.87 a share this year. The stock has climbed 218% in the last 52 weeks, and it is powering ahead this year, up 21% so far.</p><p>It’s hardly cheap, though, at 50 times estimated 2022 profits. About 13% of the shares are held short, according to FactSet.</p><p>Lyft (LYFT) also fits into the reopening theme; shares are up 178% in the last 52 weeks, including a 35% gain this year. Ride-sharing could pick up as more people head to work, meetings, and evenings out.</p><p>However, Lyft and its chief rival Uber Technologies (UBER) face rising labor costs and regulatory hurdles in Europe and other regions. Wall Street sees Lyft losing $1.08 a share this year and turning a modest profit of 17 cents in 2022. That gives it a multiple of 379 times 2022 earnings. Short interest is around 9%.</p><p>Restoration Hardware parent Restoration Hardware (RH) has been a stay-at-home winner. The stock soared 338% over the last year and it’s ahead 5% this year. The company is profitable, expected to earn $19.17 a share this year, up from an estimated $17.05 in 2020. But the stock hit a rough patch in early March as high-growth, high-multiple stocks sold off.</p><p>RH trades at 22 times 2022 earnings, which doesn’t look excessive. But It is now vulnerable to a blowup, according to Wolfe, with short-interest at 11% of the float.</p><p>Beyond Meat (BYND) has long been a battleground between alt-meat bulls and bears. The stock has surged 93% over the last 52 weeks, defying the bears, but at recent prices around $142, it’s off 36% from its 52-week high of $221.</p><p>The alt-meat trend is going strong, and Beyond is working its way into more restaurants and supermarkets, while expanding its product line. But alt-meat rivals are gaining traction. Beyond’s profits aren’t expected to roll in until 2022, when the firm is anticipated to earn 23 cents a share. At that level of profit, the stock trades at 621 times earnings.</p><p>Stocks like Beyond trade on underlying business momentum, making earnings less of a share-price driver. Still, it isn’t encouraging that Wall Street sees the losses piling up. Per-share estimates for 2021 have been lowered 12% in the last week, according to FactSet, and 2021 estimates are down 190% in the past three months.</p><p>Meanwhile, First Solar (FSLR) is riding a wave of investor demand for green stocks from ESG funds and others looking for exposure to clean energy. The company, which makes solar power systems and modules, has gained 124% over the last 52 weeks. The company has reported strong sales and bookings, but the stock is also baking in friendly climate policies from the Biden administration.</p><p>The stock has been wavering, however, after its big run. It has slumped 17% this year and it’s off more than 20% from 52-week highs around $112, recently trading around $82. Despite a favorable backdrop for green energy, First Solar’s sales and earnings are expected to fall slightly from 2021 to 2022. The stock trades at 24 times 2022 earnings, a premium to the market.</p><p>Other large-cap stocks that make Wolfe’s blowup watch list include BioMarin Pharmaceutical (BMRN), Zendesk (ZEN), and Advanced Micro Devices (AMD). Zendesk and AMD are each up more than 100% over the last year, while BioMarin has been flat. All trade at steep valuations, with Zendesk topping the list at 130 times 2022 earnings estimates.</p><p>A blowup may not be imminent in any of these names, but stocks without a significant profit in sight may fall sharply if market jitters resurface and investors start to appreciate higher earnings quality.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>10 Stocks That Are Vulnerable to a Blowup</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n10 Stocks That Are Vulnerable to a Blowup\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-15 18:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/beyond-meat-stock-expedia-lyft-vulnerable-blowup-51615588807?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Avoiding stock blowups is in every investor’s interest, but it’s getting a bit tougher.Many companies that beat fourth-quarter estimates haven’t been rewarded with higher share prices. High-growth ...</p>\n\n<a href=\"https://www.barrons.com/articles/beyond-meat-stock-expedia-lyft-vulnerable-blowup-51615588807?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BMRN":"拜玛林制药","RH":"Restoration Hardware Holdings","BYND":"Beyond Meat, Inc.","FSLR":"第一太阳能","LYFT":"Lyft, Inc.","AMD":"美国超微公司","COTY":"科蒂","EXPE":"Expedia","CVNA":"Carvana Co.","ZEN":"Zendesk Inc.","NCLH":"挪威邮轮"},"source_url":"https://www.barrons.com/articles/beyond-meat-stock-expedia-lyft-vulnerable-blowup-51615588807?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164885443","content_text":"Avoiding stock blowups is in every investor’s interest, but it’s getting a bit tougher.Many companies that beat fourth-quarter estimates haven’t been rewarded with higher share prices. High-growth stocks are facing steeper hurdles from rising bond yields. Investors appear to be rotating from growth to value and into sectors with more exposure to a cyclical economic recovery.Quite simply, fatigue may be setting into overcrowded trades and investment themes—whether those are alternative-meat producers, a travel recovery, green energy, or the continued domination of Big Tech.Against that backdrop, investors may want to tread cautiously. One way to do so: Avoid stocks with low earnings quality and high short interest—meaning there are short positions, or bearish bets, on a large percentage of a company’s shares outstanding. (A short position is when investors borrow and then sell shares, betting that a stock’s price will fall so they can buy shares back at a cheaper price.) Stocks with that combination of attributes may be most at risk of underperforming or blowing up, according to Wolfe Research.The firm ranks stocks on a relative basis within sectors by scoring earnings quality on seven financial measures, while also looking at valuation and sentiment indicators, based on fourth-quarter financials.Wolfe calls stocks scoring in the bottom 10% of earnings quality, while also seeing high short interest, “our highest conviction cohort of stocks to avoid.”One caveat: Low-quality stocks have been a popular trade—fueled by ample market liquidity and demand for riskier assets. High short interest also primes a stock for a short-squeeze, whereby traders who are short buy the stock to cover their positions, exerting upward pressure on the price. Nothing illustrates that dynamic more than the frenzied trading around GameStop (ticker: GME) this year.Beauty products maker Coty (COTY), for example, shows up on Wolfe’s screen. But it may have already had its blowup, falling 15% the day it released its earnings report in February. Barron’s was bullish on the stock in the aftermath, and it has been moving up since then.Nonetheless, plenty of other stocks on Wolfe’s watch list do seem vulnerable. Many have surged in a reopening trade or company-specific dynamics, and all trade at steep valuations. Here are 10 stocks from Wolfe’s list:Carvana (CVNA), for instance, has been a blockbuster, gaining 535% over the last 52 weeks. Investors appear to have decided that it is a disruptive force in car buying and that a pandemic-fueled shift to online sales has accelerated its momentum. However, Carvana isn’t close to reporting a profit, and is expected to lose $1.96 a share this year and 97 cents in 2022.The stock is up around 11% this year, but it has been wobbling lately and is down from its 52-week high around $315, trading recently at $287. Short interest is high at 22% of the shares outstanding, according to FactSet.Expedia Group (EXPE) has surged 32% this year. Investors expect online bookings volume to soar as consumers head for vacations this summer and fall. Wall Street doesn’t see Expedia Group earning a profit this year but expects big gains in 2022 with earnings per share of $6.04. At recent prices around $175, shares trade at 28 times 2022 earnings, a 40% premium to the S&P 500 ‘s multiple of 20 times.Norwegian Cruise Line Holdings (NCLH) is also trading on hopes for a travel rebound in 2022. Wall Street expects revenues of $1.6 billion this year, up from $1.3 billion in 2020. But the stock is riding on expectations of a surge to $6 billion in revenue in 2022. Analysts are looking for earnings of 62 cents a share in 2022, up from an expected loss of $5.87 a share this year. The stock has climbed 218% in the last 52 weeks, and it is powering ahead this year, up 21% so far.It’s hardly cheap, though, at 50 times estimated 2022 profits. About 13% of the shares are held short, according to FactSet.Lyft (LYFT) also fits into the reopening theme; shares are up 178% in the last 52 weeks, including a 35% gain this year. Ride-sharing could pick up as more people head to work, meetings, and evenings out.However, Lyft and its chief rival Uber Technologies (UBER) face rising labor costs and regulatory hurdles in Europe and other regions. Wall Street sees Lyft losing $1.08 a share this year and turning a modest profit of 17 cents in 2022. That gives it a multiple of 379 times 2022 earnings. Short interest is around 9%.Restoration Hardware parent Restoration Hardware (RH) has been a stay-at-home winner. The stock soared 338% over the last year and it’s ahead 5% this year. The company is profitable, expected to earn $19.17 a share this year, up from an estimated $17.05 in 2020. But the stock hit a rough patch in early March as high-growth, high-multiple stocks sold off.RH trades at 22 times 2022 earnings, which doesn’t look excessive. But It is now vulnerable to a blowup, according to Wolfe, with short-interest at 11% of the float.Beyond Meat (BYND) has long been a battleground between alt-meat bulls and bears. The stock has surged 93% over the last 52 weeks, defying the bears, but at recent prices around $142, it’s off 36% from its 52-week high of $221.The alt-meat trend is going strong, and Beyond is working its way into more restaurants and supermarkets, while expanding its product line. But alt-meat rivals are gaining traction. Beyond’s profits aren’t expected to roll in until 2022, when the firm is anticipated to earn 23 cents a share. At that level of profit, the stock trades at 621 times earnings.Stocks like Beyond trade on underlying business momentum, making earnings less of a share-price driver. Still, it isn’t encouraging that Wall Street sees the losses piling up. Per-share estimates for 2021 have been lowered 12% in the last week, according to FactSet, and 2021 estimates are down 190% in the past three months.Meanwhile, First Solar (FSLR) is riding a wave of investor demand for green stocks from ESG funds and others looking for exposure to clean energy. The company, which makes solar power systems and modules, has gained 124% over the last 52 weeks. The company has reported strong sales and bookings, but the stock is also baking in friendly climate policies from the Biden administration.The stock has been wavering, however, after its big run. It has slumped 17% this year and it’s off more than 20% from 52-week highs around $112, recently trading around $82. Despite a favorable backdrop for green energy, First Solar’s sales and earnings are expected to fall slightly from 2021 to 2022. The stock trades at 24 times 2022 earnings, a premium to the market.Other large-cap stocks that make Wolfe’s blowup watch list include BioMarin Pharmaceutical (BMRN), Zendesk (ZEN), and Advanced Micro Devices (AMD). Zendesk and AMD are each up more than 100% over the last year, while BioMarin has been flat. All trade at steep valuations, with Zendesk topping the list at 130 times 2022 earnings estimates.A blowup may not be imminent in any of these names, but stocks without a significant profit in sight may fall sharply if market jitters resurface and investors start to appreciate higher earnings quality.","news_type":1},"isVote":1,"tweetType":1,"viewCount":163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":322982142,"gmtCreate":1615767483186,"gmtModify":1704786162668,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Indeed this will be interesting to watch!","listText":"Indeed this will be interesting to watch!","text":"Indeed this will be interesting to watch!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322982142","repostId":"1155155337","repostType":4,"isVote":1,"tweetType":1,"viewCount":254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":328540228,"gmtCreate":1615543494764,"gmtModify":1704784342812,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Yes indeed that is true","listText":"Yes indeed that is true","text":"Yes indeed that is true","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/328540228","repostId":"1155506399","repostType":4,"isVote":1,"tweetType":1,"viewCount":235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321669546,"gmtCreate":1615429632285,"gmtModify":1704782657766,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SE\">$Sea Ltd(SE)$</a>Was a little disappointed that we didn’t hold the slope up yesterday but I guess it would be good to spend more time in consolidation mode. It could be difficult to see but will be healthier in the long run. Hoping for more sustained upside action in the months to come!","listText":"<a href=\"https://laohu8.com/S/SE\">$Sea Ltd(SE)$</a>Was a little disappointed that we didn’t hold the slope up yesterday but I guess it would be good to spend more time in consolidation mode. It could be difficult to see but will be healthier in the long run. Hoping for more sustained upside action in the months to come!","text":"$Sea Ltd(SE)$Was a little disappointed that we didn’t hold the slope up yesterday but I guess it would be good to spend more time in consolidation mode. It could be difficult to see but will be healthier in the long run. Hoping for more sustained upside action in the months to come!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321669546","isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":323711472,"gmtCreate":1615374866296,"gmtModify":1704781844010,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AYRO\">$AYRO, Inc.(AYRO)$</a>Lol","listText":"<a href=\"https://laohu8.com/S/AYRO\">$AYRO, Inc.(AYRO)$</a>Lol","text":"$AYRO, Inc.(AYRO)$Lol","images":[{"img":"https://static.tigerbbs.com/5a7a068e1f845f68e0209af558d44d34","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/323711472","isVote":1,"tweetType":1,"viewCount":111,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3571882312755933","authorId":"3571882312755933","name":"Alexngo","avatar":"https://community-static.tradeup.com/news/223e039a4ee6d691503ce2aee951d200","crmLevel":5,"crmLevelSwitch":1,"idStr":"3571882312755933","authorIdStr":"3571882312755933"},"content":"Did you average when the price dip last few days?","text":"Did you average when the price dip last few days?","html":"Did you average when the price dip last few days?"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":323739872,"gmtCreate":1615373740896,"gmtModify":1704781827744,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Must be careful","listText":"Must be careful","text":"Must be careful","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/323739872","repostId":"2118269678","repostType":4,"isVote":1,"tweetType":1,"viewCount":146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":323739389,"gmtCreate":1615373716141,"gmtModify":1704781828067,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"This is good news but I hope it sustains the bounce","listText":"This is good news but I hope it sustains the bounce","text":"This is good news but I hope it sustains the bounce","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/323739389","repostId":"2117431698","repostType":2,"isVote":1,"tweetType":1,"viewCount":157,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":323596515,"gmtCreate":1615352128437,"gmtModify":1704781549665,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"It can bounce but I hope it maintains the bounce&nbsp;","listText":"It can bounce but I hope it maintains the bounce&nbsp;","text":"It can bounce but I hope it maintains the bounce","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/323596515","repostId":"1140398434","repostType":4,"isVote":1,"tweetType":1,"viewCount":163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":323320685,"gmtCreate":1615303982947,"gmtModify":1704780943187,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SE\">$Sea Ltd(SE)$</a>My only regret is not buying when Shopee launched in Singapore a few years ago. They’re actually doing quite well in terms of public sentiment and I think they’ll do well compared to direct competitors&nbsp;","listText":"<a href=\"https://laohu8.com/S/SE\">$Sea Ltd(SE)$</a>My only regret is not buying when Shopee launched in Singapore a few years ago. They’re actually doing quite well in terms of public sentiment and I think they’ll do well compared to direct competitors&nbsp;","text":"$Sea Ltd(SE)$My only regret is not buying when Shopee launched in Singapore a few years ago. They’re actually doing quite well in terms of public sentiment and I think they’ll do well compared to direct competitors","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/323320685","isVote":1,"tweetType":1,"viewCount":69,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":323366601,"gmtCreate":1615303798003,"gmtModify":1704780934099,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Go J&amp;J!","listText":"Go J&amp;J!","text":"Go J&J!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/323366601","repostId":"1117128744","repostType":4,"repost":{"id":"1117128744","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1615298116,"share":"https://ttm.financial/m/news/1117128744?lang=&edition=fundamental","pubTime":"2021-03-09 21:55","market":"us","language":"en","title":"J&J 'under stress' to meet EU second-quarter vaccine supply goal - source","url":"https://stock-news.laohu8.com/highlight/detail?id=1117128744","media":"Reuters","summary":"Johnson & Johnson has told the European Union it is facing supply issues that may complicate plans t","content":"<p>Johnson &amp; Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its COVID-19 vaccine to the bloc in the second quarter of the year, an EU official told Reuters.</p><p>Any delay would be a further blow to EU’s vaccination plans, which have been hampered by bumpy supplies from other vaccine makers and a slow rollout of shots in many member states.</p><p>J&amp;J told the EU last week that issues with the supply of vaccine ingredients and equipment meant it was “under stress” to meet the goal of delivering 55 million doses by the end of June, the EU official - who is directly involved in confidential talks with the U.S. company - told Reuters on condition of anonymity.</p><p>The official added the company had said it was not impossible to meet the goal, but that it showed caution.</p><p>J&amp;J’s vaccine, which requires only one dose for protection, is expected to be approved on March 11 for use in the EU by the bloc’s regulator. EU officials have said deliveries could start in April.</p><p>The company has committed to deliver 200 million doses of its vaccine to the bloc this year.</p><p>“Aligned with our agreement, we expect to begin supplying our commitment of 200 million doses to the European Union in the second quarter of 2021,” J&amp;J said in a statement, declining to comment on possible delays or the second-quarter target.</p><p>J&amp;J began rolling out its vaccine in the United States this month, with a target of delivering 100 million doses by the end of May, but has nearly halved its delivery forecasts for March to 20 million doses as it ramps up new manufacturing facilities.</p><p>A spokesman for the European Commission declined to comment on J&amp;J’s delivery schedules. The Commission coordinates EU talks with vaccine makers and has come under fire for its role in a vaccination strategy that has so far lagged behind those in Britain and the United States.</p><p>An internal document from the German health ministry dated Feb. 22, and a schedule published by the Italian health ministry on March 3, confirm that under the EU contract J&amp;J had committed to delivering around 55 million doses in the second quarter.</p><p>That includes about 10 million to Germany and 7.3 million to Italy. Supplies are expected to double in the third quarter, the two schedules show.</p><p>But J&amp;J has not yet provided figures on planned deliveries. “We don’t really know how much to expect,” the EU official said.</p><p><b>LATER START</b></p><p>Dutch Health Minister Hugo de Jonge told reporters he expected the company, which produces its COVID-19 vaccines for the EU in the Netherlands, to meet its second-quarter target of about three million doses for the country, although with limited deliveries in April and a ramp-up later in the quarter.</p><p>Ireland also expects J&amp;J to begin supplies a bit later in April than initially planned, with the largest deliveries at the end of the second quarter, the head of the country’s health service operator said on Tuesday, confirming earlier estimates for supplies through June.</p><p>EU countries raised questions earlier in the year about J&amp;J’s production network and contract with the EU, which would require it to send vaccines made at its Dutch factory to the United States for bottling before being shipped back to the EU.</p><p>A second EU official, also involved in talks with vaccine makers, said the bloc was trying to boost industrial capacity to bottle more shots in the EU, as part of plans to smooth out J&amp;J deliveries.</p><p>Actual deliveries have often diverged from contractual obligations as vaccine makers have struggled to ship millions of shots at breakneck pace amid the pandemic.</p><p>AstraZeneca cut planned first-quarter deliveries of its vaccine to the EU to 40 million doses from 90 million, and told the bloc second-quarter supplies would be halved. It later said it was striving to provide more shots from outside Europe.</p><p>Pfizer/BioNTech and Moderna have also faced delays in their deliveries to the EU, but kept their targets for the first quarter.</p><p>Under the contract with J&amp;J, the EU has also the option of ordering another 200 million doses, which if exercised would double its supply from the U.S. firm.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J 'under stress' to meet EU second-quarter vaccine supply goal - source</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J 'under stress' to meet EU second-quarter vaccine supply goal - source\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-09 21:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Johnson &amp; Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its COVID-19 vaccine to the bloc in the second quarter of the year, an EU official told Reuters.</p><p>Any delay would be a further blow to EU’s vaccination plans, which have been hampered by bumpy supplies from other vaccine makers and a slow rollout of shots in many member states.</p><p>J&amp;J told the EU last week that issues with the supply of vaccine ingredients and equipment meant it was “under stress” to meet the goal of delivering 55 million doses by the end of June, the EU official - who is directly involved in confidential talks with the U.S. company - told Reuters on condition of anonymity.</p><p>The official added the company had said it was not impossible to meet the goal, but that it showed caution.</p><p>J&amp;J’s vaccine, which requires only one dose for protection, is expected to be approved on March 11 for use in the EU by the bloc’s regulator. EU officials have said deliveries could start in April.</p><p>The company has committed to deliver 200 million doses of its vaccine to the bloc this year.</p><p>“Aligned with our agreement, we expect to begin supplying our commitment of 200 million doses to the European Union in the second quarter of 2021,” J&amp;J said in a statement, declining to comment on possible delays or the second-quarter target.</p><p>J&amp;J began rolling out its vaccine in the United States this month, with a target of delivering 100 million doses by the end of May, but has nearly halved its delivery forecasts for March to 20 million doses as it ramps up new manufacturing facilities.</p><p>A spokesman for the European Commission declined to comment on J&amp;J’s delivery schedules. The Commission coordinates EU talks with vaccine makers and has come under fire for its role in a vaccination strategy that has so far lagged behind those in Britain and the United States.</p><p>An internal document from the German health ministry dated Feb. 22, and a schedule published by the Italian health ministry on March 3, confirm that under the EU contract J&amp;J had committed to delivering around 55 million doses in the second quarter.</p><p>That includes about 10 million to Germany and 7.3 million to Italy. Supplies are expected to double in the third quarter, the two schedules show.</p><p>But J&amp;J has not yet provided figures on planned deliveries. “We don’t really know how much to expect,” the EU official said.</p><p><b>LATER START</b></p><p>Dutch Health Minister Hugo de Jonge told reporters he expected the company, which produces its COVID-19 vaccines for the EU in the Netherlands, to meet its second-quarter target of about three million doses for the country, although with limited deliveries in April and a ramp-up later in the quarter.</p><p>Ireland also expects J&amp;J to begin supplies a bit later in April than initially planned, with the largest deliveries at the end of the second quarter, the head of the country’s health service operator said on Tuesday, confirming earlier estimates for supplies through June.</p><p>EU countries raised questions earlier in the year about J&amp;J’s production network and contract with the EU, which would require it to send vaccines made at its Dutch factory to the United States for bottling before being shipped back to the EU.</p><p>A second EU official, also involved in talks with vaccine makers, said the bloc was trying to boost industrial capacity to bottle more shots in the EU, as part of plans to smooth out J&amp;J deliveries.</p><p>Actual deliveries have often diverged from contractual obligations as vaccine makers have struggled to ship millions of shots at breakneck pace amid the pandemic.</p><p>AstraZeneca cut planned first-quarter deliveries of its vaccine to the EU to 40 million doses from 90 million, and told the bloc second-quarter supplies would be halved. It later said it was striving to provide more shots from outside Europe.</p><p>Pfizer/BioNTech and Moderna have also faced delays in their deliveries to the EU, but kept their targets for the first quarter.</p><p>Under the contract with J&amp;J, the EU has also the option of ordering another 200 million doses, which if exercised would double its supply from the U.S. firm.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117128744","content_text":"Johnson & Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its COVID-19 vaccine to the bloc in the second quarter of the year, an EU official told Reuters.Any delay would be a further blow to EU’s vaccination plans, which have been hampered by bumpy supplies from other vaccine makers and a slow rollout of shots in many member states.J&J told the EU last week that issues with the supply of vaccine ingredients and equipment meant it was “under stress” to meet the goal of delivering 55 million doses by the end of June, the EU official - who is directly involved in confidential talks with the U.S. company - told Reuters on condition of anonymity.The official added the company had said it was not impossible to meet the goal, but that it showed caution.J&J’s vaccine, which requires only one dose for protection, is expected to be approved on March 11 for use in the EU by the bloc’s regulator. EU officials have said deliveries could start in April.The company has committed to deliver 200 million doses of its vaccine to the bloc this year.“Aligned with our agreement, we expect to begin supplying our commitment of 200 million doses to the European Union in the second quarter of 2021,” J&J said in a statement, declining to comment on possible delays or the second-quarter target.J&J began rolling out its vaccine in the United States this month, with a target of delivering 100 million doses by the end of May, but has nearly halved its delivery forecasts for March to 20 million doses as it ramps up new manufacturing facilities.A spokesman for the European Commission declined to comment on J&J’s delivery schedules. The Commission coordinates EU talks with vaccine makers and has come under fire for its role in a vaccination strategy that has so far lagged behind those in Britain and the United States.An internal document from the German health ministry dated Feb. 22, and a schedule published by the Italian health ministry on March 3, confirm that under the EU contract J&J had committed to delivering around 55 million doses in the second quarter.That includes about 10 million to Germany and 7.3 million to Italy. Supplies are expected to double in the third quarter, the two schedules show.But J&J has not yet provided figures on planned deliveries. “We don’t really know how much to expect,” the EU official said.LATER STARTDutch Health Minister Hugo de Jonge told reporters he expected the company, which produces its COVID-19 vaccines for the EU in the Netherlands, to meet its second-quarter target of about three million doses for the country, although with limited deliveries in April and a ramp-up later in the quarter.Ireland also expects J&J to begin supplies a bit later in April than initially planned, with the largest deliveries at the end of the second quarter, the head of the country’s health service operator said on Tuesday, confirming earlier estimates for supplies through June.EU countries raised questions earlier in the year about J&J’s production network and contract with the EU, which would require it to send vaccines made at its Dutch factory to the United States for bottling before being shipped back to the EU.A second EU official, also involved in talks with vaccine makers, said the bloc was trying to boost industrial capacity to bottle more shots in the EU, as part of plans to smooth out J&J deliveries.Actual deliveries have often diverged from contractual obligations as vaccine makers have struggled to ship millions of shots at breakneck pace amid the pandemic.AstraZeneca cut planned first-quarter deliveries of its vaccine to the EU to 40 million doses from 90 million, and told the bloc second-quarter supplies would be halved. It later said it was striving to provide more shots from outside Europe.Pfizer/BioNTech and Moderna have also faced delays in their deliveries to the EU, but kept their targets for the first quarter.Under the contract with J&J, the EU has also the option of ordering another 200 million doses, which if exercised would double its supply from the U.S. firm.","news_type":1},"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320265056,"gmtCreate":1615119214675,"gmtModify":1704778770806,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/320265056","repostId":"1169596583","repostType":4,"repost":{"id":"1169596583","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1614958557,"share":"https://ttm.financial/m/news/1169596583?lang=&edition=fundamental","pubTime":"2021-03-05 23:35","market":"us","language":"en","title":"Palantir plunged more than 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169596583","media":"老虎资讯综合","summary":"(March 5)&nbsp;Palantir plunged more than 13%.","content":"<p>(March 5)&nbsp;Palantir plunged more than 13%.</p><p><img src=\"https://static.tigerbbs.com/13f756ec57cca85c31b6be070941d7c1\" tg-width=\"1059\" tg-height=\"499\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir plunged more than 13%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir plunged more than 13%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-03-05 23:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(March 5)&nbsp;Palantir plunged more than 13%.</p><p><img src=\"https://static.tigerbbs.com/13f756ec57cca85c31b6be070941d7c1\" tg-width=\"1059\" tg-height=\"499\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169596583","content_text":"(March 5) Palantir plunged more than 13%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":58,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":323711472,"gmtCreate":1615374866296,"gmtModify":1704781844010,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AYRO\">$AYRO, Inc.(AYRO)$</a>Lol","listText":"<a href=\"https://laohu8.com/S/AYRO\">$AYRO, Inc.(AYRO)$</a>Lol","text":"$AYRO, Inc.(AYRO)$Lol","images":[{"img":"https://static.tigerbbs.com/5a7a068e1f845f68e0209af558d44d34","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/323711472","isVote":1,"tweetType":1,"viewCount":111,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3571882312755933","authorId":"3571882312755933","name":"Alexngo","avatar":"https://community-static.tradeup.com/news/223e039a4ee6d691503ce2aee951d200","crmLevel":5,"crmLevelSwitch":1,"idStr":"3571882312755933","authorIdStr":"3571882312755933"},"content":"Did you average when the price dip last few days?","text":"Did you average when the price dip last few days?","html":"Did you average when the price dip last few days?"}],"imageCount":1,"langContent":"EN","totalScore":0},{"id":125013748,"gmtCreate":1624636375684,"gmtModify":1703842504505,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Good to think about it!","listText":"Good to think about it!","text":"Good to think about it!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/125013748","repostId":"2146079086","repostType":4,"repost":{"id":"2146079086","pubTimestamp":1624634220,"share":"https://ttm.financial/m/news/2146079086?lang=&edition=fundamental","pubTime":"2021-06-25 23:17","market":"us","language":"en","title":"It's Not Too Late to Take Advantage of NVIDIA's Stock Split. Here's Why","url":"https://stock-news.laohu8.com/highlight/detail?id=2146079086","media":"Motley Fool","summary":"There's an unusual component to this stock split investors need to understand.","content":"<p>Most stock splits are pretty straightforward affairs. A company announces a stock split and advises investors of how many additional shares they will receive, the record date of the transaction, and when the new shares will be distributed.</p>\n<p>In many ways, the upcoming stock split for <b>NVIDIA</b> (NASDAQ:NVDA) is no different. In conjunction with its fiscal 2022 first-quarter earnings report (ended May 2, 2021), the chipmaker announced that its board of directors declared a four-for-<a href=\"https://laohu8.com/S/AONE\">one</a> stock split, payable in the form of a stock dividend. This move was conditional on NVIDIA stockholders voting to approve to increase the number of authorized shares from 2 billion to 4 billion.</p>\n<p>Due to a quirk in this particular case (more on that in a minute), while it <i>appears</i> investors have already missed the opportunity to take advantage of the NVIDIA stock split, that simply isn't the case.</p>\n<p><img src=\"https://static.tigerbbs.com/10b74b78ba82e9df1e981738dfafe1bc\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>The devil's in the details</h3>\n<p>At the company's 2021 annual meeting of stockholders, which was held on June 3, shareholders approved the measure to increase the number of outstanding shares, setting the stage for the stock split to move forward. Each shareholder of record <i>as of June 21</i> will receive three additional shares of NVIDIA stock for each <a href=\"https://laohu8.com/S/AONE.U\">one</a> they own, which will be distributed after the market close on July 19. The stock will start trading on a split-adjusted basis when the market opens on Tuesday, July 20.</p>\n<p>To give some context to the numbers, here's an example of how it will work, though the final numbers will vary based on the then-current stock price. For each share of NVIDIA stock that an investor holds -- currently worth roughly $760 -- post-split, shareholders would own a total of four shares priced at $190 each.</p>\n<h3>The odd quirk</h3>\n<p>What sets NVIDIA's stock split apart from many others is the extraordinary length of time between the record date and the distribution date of the new, split shares. The record date is the date by which investors must own the stock in order to be eligible to receive additional shares created by the stock split, which occurs on the effective date. Typically, there are just a few days between the two.</p>\n<p>For example, in the recent 10-for-one stock split initiated by <b>The Trade Desk</b> (NASDAQ:TTD), shareholders of record as of June 9, 2021 received nine additional shares of stock, which were distributed after the close of trading on June 16, 2021 -- or a period of about a week after the record date. This was very similar to a couple of high-profile stock splits that happened late last year. <b>Apple</b> (NASDAQ:AAPL) and <b>Tesla</b> (NASDAQ:TSLA) each split their shares in August, with record dates of Aug. 24 and Aug. 21, respectively, and both stocks began trading split-adjusted&nbsp;on Aug. 31.</p>\n<p>In the case of NVIDIA, however, the period between the two is a whopping four weeks long. So what happens to investors who buy between the record date and the effective date? Are they left holding the bag?</p>\n<p><img src=\"https://static.tigerbbs.com/97eae1602703c6cf3c0c5c986a02e099\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>The good news</h3>\n<p>What's missing from NVIDIA's press release is the ex-dividend date. Because the stock split is being initiated in the form of a stock dividend, the ex-dividend date governs which investors are eligible to receive the newly split shares. In this case, NVIDIA's stock split goes ex-dividend on July 19, according to a spokesperson for brokerage house <b>Charles Schwab</b>.</p>\n<p>This means that investors can buy NVIDIA shares right up to July 19, and still be eligible to receive the additional shares from the stock split once the shares begin trading on a split-adjusted basis when the market opens July 20.</p>\n<p>It's also important to point out that this stock split doesn't do anything to change the underlying value of NVIDIA as a company -- it merely cleaves it into a greater number of ownership segments. There are plenty of reasons to be bullish and invest in NVIDIA, but investors shouldn't buy the stock based <i>solely</i> on the upcoming stock split.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>It's Not Too Late to Take Advantage of NVIDIA's Stock Split. Here's Why</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIt's Not Too Late to Take Advantage of NVIDIA's Stock Split. Here's Why\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 23:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/25/not-too-late-take-advantage-nvidias-stock-split/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Most stock splits are pretty straightforward affairs. A company announces a stock split and advises investors of how many additional shares they will receive, the record date of the transaction, and ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/25/not-too-late-take-advantage-nvidias-stock-split/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVDA":"英伟达","03086":"华夏纳指","09086":"华夏纳指-U"},"source_url":"https://www.fool.com/investing/2021/06/25/not-too-late-take-advantage-nvidias-stock-split/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2146079086","content_text":"Most stock splits are pretty straightforward affairs. A company announces a stock split and advises investors of how many additional shares they will receive, the record date of the transaction, and when the new shares will be distributed.\nIn many ways, the upcoming stock split for NVIDIA (NASDAQ:NVDA) is no different. In conjunction with its fiscal 2022 first-quarter earnings report (ended May 2, 2021), the chipmaker announced that its board of directors declared a four-for-one stock split, payable in the form of a stock dividend. This move was conditional on NVIDIA stockholders voting to approve to increase the number of authorized shares from 2 billion to 4 billion.\nDue to a quirk in this particular case (more on that in a minute), while it appears investors have already missed the opportunity to take advantage of the NVIDIA stock split, that simply isn't the case.\n\nImage source: Getty Images.\nThe devil's in the details\nAt the company's 2021 annual meeting of stockholders, which was held on June 3, shareholders approved the measure to increase the number of outstanding shares, setting the stage for the stock split to move forward. Each shareholder of record as of June 21 will receive three additional shares of NVIDIA stock for each one they own, which will be distributed after the market close on July 19. The stock will start trading on a split-adjusted basis when the market opens on Tuesday, July 20.\nTo give some context to the numbers, here's an example of how it will work, though the final numbers will vary based on the then-current stock price. For each share of NVIDIA stock that an investor holds -- currently worth roughly $760 -- post-split, shareholders would own a total of four shares priced at $190 each.\nThe odd quirk\nWhat sets NVIDIA's stock split apart from many others is the extraordinary length of time between the record date and the distribution date of the new, split shares. The record date is the date by which investors must own the stock in order to be eligible to receive additional shares created by the stock split, which occurs on the effective date. Typically, there are just a few days between the two.\nFor example, in the recent 10-for-one stock split initiated by The Trade Desk (NASDAQ:TTD), shareholders of record as of June 9, 2021 received nine additional shares of stock, which were distributed after the close of trading on June 16, 2021 -- or a period of about a week after the record date. This was very similar to a couple of high-profile stock splits that happened late last year. Apple (NASDAQ:AAPL) and Tesla (NASDAQ:TSLA) each split their shares in August, with record dates of Aug. 24 and Aug. 21, respectively, and both stocks began trading split-adjusted on Aug. 31.\nIn the case of NVIDIA, however, the period between the two is a whopping four weeks long. So what happens to investors who buy between the record date and the effective date? Are they left holding the bag?\n\nImage source: Getty Images.\nThe good news\nWhat's missing from NVIDIA's press release is the ex-dividend date. Because the stock split is being initiated in the form of a stock dividend, the ex-dividend date governs which investors are eligible to receive the newly split shares. In this case, NVIDIA's stock split goes ex-dividend on July 19, according to a spokesperson for brokerage house Charles Schwab.\nThis means that investors can buy NVIDIA shares right up to July 19, and still be eligible to receive the additional shares from the stock split once the shares begin trading on a split-adjusted basis when the market opens July 20.\nIt's also important to point out that this stock split doesn't do anything to change the underlying value of NVIDIA as a company -- it merely cleaves it into a greater number of ownership segments. There are plenty of reasons to be bullish and invest in NVIDIA, but investors shouldn't buy the stock based solely on the upcoming stock split.","news_type":1},"isVote":1,"tweetType":1,"viewCount":273,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126867391,"gmtCreate":1624551772513,"gmtModify":1703840275896,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"That’s good news","listText":"That’s good news","text":"That’s good news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/126867391","repostId":"2145704596","repostType":4,"isVote":1,"tweetType":1,"viewCount":158,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":323739872,"gmtCreate":1615373740896,"gmtModify":1704781827744,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Must be careful","listText":"Must be careful","text":"Must be careful","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/323739872","repostId":"2118269678","repostType":4,"repost":{"id":"2118269678","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1615370220,"share":"https://ttm.financial/m/news/2118269678?lang=&edition=fundamental","pubTime":"2021-03-10 17:57","market":"us","language":"en","title":"Investors blinded by over-optimism on vaccine rollout must see these risks, warns economist","url":"https://stock-news.laohu8.com/highlight/detail?id=2118269678","media":"Dow Jones","summary":"Enthusiasm for President Joe Biden's coronavirus relief package, the rollout of vaccines, and Chines","content":"<blockquote>\n Enthusiasm for President Joe Biden's coronavirus relief package, the rollout of vaccines, and Chinese growth have made investors blind to these risks, warns this economist.\n</blockquote>\n<p>Enthusiasm for President Joe Biden's coronavirus relief package, the rollout of vaccines, and Chinese growth have made investors blind to these risks, warns a leading economist.</p>\n<p>Taimur Baig, chief economist at Singapore's DBS bank questions \"are we getting ahead of ourselves in beginning to look past the pandemic?\" Already, he notes, that bond yields have been firming \"in expectation of strong growth.\"</p>\n<p>He warns, in countries like the U.S., where vaccination pace has picked up, there will be a tendency among the population to let their guard down, and give up on wearing masks and social-distance requirements, causing a resurgence in infections.</p>\n<p>\"Outside of a few developed countries, the rate of vaccination is meager at the present stage\", he wrote in a Mar. 8 note. \"Vaccination-driven herd immunity is many months, if not years, away. Particularly worrisome is that with virus raging through the globe over the past year, a few potent variants have emerged.\"</p>\n<p>He says easing up on protective measures when variants are spreading could prove to be a huge mistake in the coming months, and says mask wearing and social distancing is absolutely critical.</p>\n<p>\"Otherwise, we are concerned that the SARS-Cov2 variants could end up making the market's normalization trades look highly premature,\" he warned.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investors blinded by over-optimism on vaccine rollout must see these risks, warns economist</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvestors blinded by over-optimism on vaccine rollout must see these risks, warns economist\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-03-10 17:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<blockquote>\n Enthusiasm for President Joe Biden's coronavirus relief package, the rollout of vaccines, and Chinese growth have made investors blind to these risks, warns this economist.\n</blockquote>\n<p>Enthusiasm for President Joe Biden's coronavirus relief package, the rollout of vaccines, and Chinese growth have made investors blind to these risks, warns a leading economist.</p>\n<p>Taimur Baig, chief economist at Singapore's DBS bank questions \"are we getting ahead of ourselves in beginning to look past the pandemic?\" Already, he notes, that bond yields have been firming \"in expectation of strong growth.\"</p>\n<p>He warns, in countries like the U.S., where vaccination pace has picked up, there will be a tendency among the population to let their guard down, and give up on wearing masks and social-distance requirements, causing a resurgence in infections.</p>\n<p>\"Outside of a few developed countries, the rate of vaccination is meager at the present stage\", he wrote in a Mar. 8 note. \"Vaccination-driven herd immunity is many months, if not years, away. Particularly worrisome is that with virus raging through the globe over the past year, a few potent variants have emerged.\"</p>\n<p>He says easing up on protective measures when variants are spreading could prove to be a huge mistake in the coming months, and says mask wearing and social distancing is absolutely critical.</p>\n<p>\"Otherwise, we are concerned that the SARS-Cov2 variants could end up making the market's normalization trades look highly premature,\" he warned.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2118269678","content_text":"Enthusiasm for President Joe Biden's coronavirus relief package, the rollout of vaccines, and Chinese growth have made investors blind to these risks, warns this economist.\n\nEnthusiasm for President Joe Biden's coronavirus relief package, the rollout of vaccines, and Chinese growth have made investors blind to these risks, warns a leading economist.\nTaimur Baig, chief economist at Singapore's DBS bank questions \"are we getting ahead of ourselves in beginning to look past the pandemic?\" Already, he notes, that bond yields have been firming \"in expectation of strong growth.\"\nHe warns, in countries like the U.S., where vaccination pace has picked up, there will be a tendency among the population to let their guard down, and give up on wearing masks and social-distance requirements, causing a resurgence in infections.\n\"Outside of a few developed countries, the rate of vaccination is meager at the present stage\", he wrote in a Mar. 8 note. \"Vaccination-driven herd immunity is many months, if not years, away. Particularly worrisome is that with virus raging through the globe over the past year, a few potent variants have emerged.\"\nHe says easing up on protective measures when variants are spreading could prove to be a huge mistake in the coming months, and says mask wearing and social distancing is absolutely critical.\n\"Otherwise, we are concerned that the SARS-Cov2 variants could end up making the market's normalization trades look highly premature,\" he warned.","news_type":1},"isVote":1,"tweetType":1,"viewCount":146,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":899885493,"gmtCreate":1628173737712,"gmtModify":1703502597837,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/BITF\">$Bitfarms Ltd.(BITF)$</a>Set the wrong buy limit but I guess 10% profit is still better than nothing&nbsp;","listText":"<a href=\"https://laohu8.com/S/BITF\">$Bitfarms Ltd.(BITF)$</a>Set the wrong buy limit but I guess 10% profit is still better than nothing&nbsp;","text":"$Bitfarms Ltd.(BITF)$Set the wrong buy limit but I guess 10% profit is still better than nothing","images":[{"img":"https://static.tigerbbs.com/803c9b4ab887314e0ebb7722c4770c51","width":"1170","height":"2026"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/899885493","isVote":1,"tweetType":1,"viewCount":197,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":322982142,"gmtCreate":1615767483186,"gmtModify":1704786162668,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Indeed this will be interesting to watch!","listText":"Indeed this will be interesting to watch!","text":"Indeed this will be interesting to watch!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322982142","repostId":"1155155337","repostType":4,"repost":{"id":"1155155337","pubTimestamp":1615765765,"share":"https://ttm.financial/m/news/1155155337?lang=&edition=fundamental","pubTime":"2021-03-15 07:49","market":"us","language":"en","title":"Pinduoduo, Nike,AMD, Lennar, and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1155155337","media":"Barrons","summary":"The earnings calendar is sparse this week. The few major companies reporting include home-builder Le","content":"<p>The earnings calendar is sparse this week. The few major companies reporting include home-builder&nbsp;Lennaron Tuesday and Pinduoduo,business-services firm&nbsp;Cintason Wednesday. Thursday will be more interesting as&nbsp;Nike,FedEx,and&nbsp;Dollar General&nbsp;report.Advanced Micro Deviceswill also host an event on Monday to unveil new chips.</p><p>The economic calendar this week will be more eventful. The Federal Reserve’s monetary policy committee’s March meeting concludes on Wednesday, with its latest decision&nbsp;and a press conference from chairman Jerome Powell coming that afternoon. TheBank of Japanwill announce its latest policy move on Friday.</p><p>Economic data out this week includes the Census Bureau’s retail-sales data for February on Tuesday, along with the National Association of Home Builders’ NAHB/Wells FargoHousing Market index for March. Then on Wednesday, the Census Bureau reports residential construction data for February. And on Thursday, the Conference Board releases its Leading Economic index for February.</p><p><b>Monday 3/15</b></p><p>Advanced Micro Devices hosts a conference call in conjunction with the launch of its third-generation EPYC processors. Senior management, including CEO Lisa Su, will give presentations on the new chips. AMD shares doubled last year, making them the 10th best performers in the&nbsp;S&amp;P 500.</p><p><b>The Federal Reserve</b>&nbsp;Bank of New York releases its Empire State Manufacturing Survey for March. The consensus estimate is for a 16.5 reading, versus February’s 12.1. The index has had eight consecutive months of positive readings, indicating improving conditions in the region’s manufacturing sector.</p><p><b>Tuesday 3/16</b></p><p><b>CrowdStrike Holdings</b>&nbsp;and Lennar report quarterly results.</p><p><b>The National Association</b>&nbsp;of Home Builders releases its NAHB/Wells Fargo Housing Market index for March. Economists forecast an 84 reading, even with February’s. The index is off its all-time high of 90, set last November, but home builders remain bullish on the housing market.</p><p><b>The Census Bureau</b>&nbsp;reports retail-sales data for February. Expectations are for a 0.7% month-over-month decline, after a 5.3% jump in January. Excluding autos, spending is seen edging down 0.1%, compared with a 5.9% increase previously.</p><p><b>Wednesday 3/17</b></p><p><b>The Federal Open Market Committee</b>announces its monetary-policy decision. The Federal Reserve has stressed that it will keep interest rates near zero through 2023, but might tweak its bond-buying program.</p><p><b>Cintas and Five Below</b>&nbsp;report earnings.</p><p><b>Pinduoduo</b>&nbsp;report earnings.</p><p><b>The Census Bureau</b>&nbsp;reports residential construction data for February. The consensus call is for a seasonally adjusted annual rate of 1.57 million housing starts, in line with the January figure. Housing starts remain just off their post-financial-crisis peak.</p><p><b>Thursday 3/18</b></p><p>Accenture,Dollar General, FedEx, and Nike hold conference calls to discuss quarterly results.</p><p><b>The Conference Board</b>&nbsp;releases its Leading Economic index for February. Economists forecast a 0.4% monthly rise. The LEI has increased every month since last April, though the rate of growth has slowed since the third quarter of last year.</p><p><b>The Department of Labor</b>&nbsp;reports jobless claims for the week ended on March 13. This past week’s total of 712,000claims was the second lowest since the beginning of the Covid-19 pandemic.</p><p><b>Friday 3/19</b></p><p><b>The Bank of Japan</b>&nbsp;announces its monetary-policy decision after a two-day meeting. The central bank is widely expected to keep its key short-term interest rate unchanged, at a negative 0.1%. The BOJ also will review its policy tools during the meeting.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pinduoduo, Nike,AMD, Lennar, and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPinduoduo, Nike,AMD, Lennar, and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-15 07:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/nike-fedex-amd-lennar-and-other-stocks-for-investors-to-watch-this-week-51615748409?mod=hp_LEAD_2><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The earnings calendar is sparse this week. The few major companies reporting include home-builder Lennaron Tuesday and Pinduoduo,business-services firm Cintason Wednesday. Thursday will be more ...</p>\n\n<a href=\"https://www.barrons.com/articles/nike-fedex-amd-lennar-and-other-stocks-for-investors-to-watch-this-week-51615748409?mod=hp_LEAD_2\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PDD":"拼多多","FDX":"联邦快递","NKE":"耐克","AMD":"美国超微公司"},"source_url":"https://www.barrons.com/articles/nike-fedex-amd-lennar-and-other-stocks-for-investors-to-watch-this-week-51615748409?mod=hp_LEAD_2","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155155337","content_text":"The earnings calendar is sparse this week. The few major companies reporting include home-builder Lennaron Tuesday and Pinduoduo,business-services firm Cintason Wednesday. Thursday will be more interesting as Nike,FedEx,and Dollar General report.Advanced Micro Deviceswill also host an event on Monday to unveil new chips.The economic calendar this week will be more eventful. The Federal Reserve’s monetary policy committee’s March meeting concludes on Wednesday, with its latest decision and a press conference from chairman Jerome Powell coming that afternoon. TheBank of Japanwill announce its latest policy move on Friday.Economic data out this week includes the Census Bureau’s retail-sales data for February on Tuesday, along with the National Association of Home Builders’ NAHB/Wells FargoHousing Market index for March. Then on Wednesday, the Census Bureau reports residential construction data for February. And on Thursday, the Conference Board releases its Leading Economic index for February.Monday 3/15Advanced Micro Devices hosts a conference call in conjunction with the launch of its third-generation EPYC processors. Senior management, including CEO Lisa Su, will give presentations on the new chips. AMD shares doubled last year, making them the 10th best performers in the S&P 500.The Federal Reserve Bank of New York releases its Empire State Manufacturing Survey for March. The consensus estimate is for a 16.5 reading, versus February’s 12.1. The index has had eight consecutive months of positive readings, indicating improving conditions in the region’s manufacturing sector.Tuesday 3/16CrowdStrike Holdings and Lennar report quarterly results.The National Association of Home Builders releases its NAHB/Wells Fargo Housing Market index for March. Economists forecast an 84 reading, even with February’s. The index is off its all-time high of 90, set last November, but home builders remain bullish on the housing market.The Census Bureau reports retail-sales data for February. Expectations are for a 0.7% month-over-month decline, after a 5.3% jump in January. Excluding autos, spending is seen edging down 0.1%, compared with a 5.9% increase previously.Wednesday 3/17The Federal Open Market Committeeannounces its monetary-policy decision. The Federal Reserve has stressed that it will keep interest rates near zero through 2023, but might tweak its bond-buying program.Cintas and Five Below report earnings.Pinduoduo report earnings.The Census Bureau reports residential construction data for February. The consensus call is for a seasonally adjusted annual rate of 1.57 million housing starts, in line with the January figure. Housing starts remain just off their post-financial-crisis peak.Thursday 3/18Accenture,Dollar General, FedEx, and Nike hold conference calls to discuss quarterly results.The Conference Board releases its Leading Economic index for February. Economists forecast a 0.4% monthly rise. The LEI has increased every month since last April, though the rate of growth has slowed since the third quarter of last year.The Department of Labor reports jobless claims for the week ended on March 13. This past week’s total of 712,000claims was the second lowest since the beginning of the Covid-19 pandemic.Friday 3/19The Bank of Japan announces its monetary-policy decision after a two-day meeting. The central bank is widely expected to keep its key short-term interest rate unchanged, at a negative 0.1%. The BOJ also will review its policy tools during the meeting.","news_type":1},"isVote":1,"tweetType":1,"viewCount":254,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":328540228,"gmtCreate":1615543494764,"gmtModify":1704784342812,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Yes indeed that is true","listText":"Yes indeed that is true","text":"Yes indeed that is true","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/328540228","repostId":"1155506399","repostType":4,"repost":{"id":"1155506399","pubTimestamp":1615543208,"share":"https://ttm.financial/m/news/1155506399?lang=&edition=fundamental","pubTime":"2021-03-12 18:00","market":"us","language":"en","title":"Don’t be fooled by the ‘value’ tag on these tech stocks. Many can provide plenty of growth too","url":"https://stock-news.laohu8.com/highlight/detail?id=1155506399","media":"MarketWatch","summary":"Facebook, Oracle and Micron Technology are reasonably valued when considering the outlook for their ","content":"<p>Facebook, Oracle and Micron Technology are reasonably valued when considering the outlook for their sales growth.</p>\n<p>With another round of federal stimulus on the way and expectations for solid growth for the U.S. economy this year, value stocks have been rallying. Stocks with low valuations tend to do well during economic growth phases.</p>\n<p>Mark DeCambre&nbsp;underlined the value rallyby pointing out that the Dow Jones Industrial Average&nbsp;ended at a record high Dec. 10, while the Nasdaq Composite Index&nbsp;was still in a correction.</p>\n<p>But what about tech stocks? There’s plenty of value there too, as you can see in the screen below.</p>\n<p>Economists&nbsp;polled by MarketWatch expect the U.S. economy to expand by 6% in 2021. Yes, that’s coming off a 3.5% contraction in 2020, according to the&nbsp;latest estimate&nbsp;from the Bureau of Economic Analysis. But the 2021 growth rate would be the fastest since 1984, according to&nbsp;World Bank&nbsp;data.</p>\n<p><b>Tech value stock screen</b></p>\n<p>There are several definitions of value stocks, but generally they are those that trade at lower valuations to earnings and typically grow their sales at a slower pace. That said, an individual value stock might also be considered a growth stock. This is illustrated by the Russell indexes.</p>\n<p>The Russell 1000 Index&nbsp;is made up of the 1,000 largest publicly traded U.S. companies by market capitalization and is reconstituted each year in June. Selected from the Russell 1000 are the Russell 1000 Value Index,which has 849 stocks, and the Russell 1000 Growth Index,which has 453 stocks. The groups overlap, with 291 stocks in both. You can read how FTSE Russell describes the makeup of its indexeshere.</p>\n<p>So an easy way to play value at this time is to buy shares of an exchange traded fund that tracks the Russell 1000 Value Index,such as the iShares Russell 1000 Value ETF&nbsp;or the Vanguard Russell 1000 Value ETF.As always, do your own research on any investment you consider to make an informed decisions.</p>\n<p>For a large-cap technology value screen, we started with the information technology sector of the S&amp;P 500 Index.Here’s how this sector’s weighted aggregate forward price-to-earnings ratio has increased over the past five years:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/448e8db17465fbd7031f10b78f718961\" tg-width=\"1259\" tg-height=\"988\"><span>(FACTSET)</span></p>\n<p>The sector’s forward P/E his risen to 25.4.</p>\n<p>This doesn’t mean “expensive” tech stocks can’t be excellent investments. Salesforce.com&nbsp;was trading at a forward P/E of 68.7 five years ago, and the stock has nearly tripled since then.</p>\n<p>Getting back to the S&amp;P 500 tech value screen, we then added tech-oriented stocks in the communications services sector, including videogame developers and Facebook Inc.,Alphabet Inc.,Netflix Inc.&nbsp;and Twitter Inc..That brought the list up to 82 stocks. Two of the videogame developers made the cut, but among the four companies named above, only Facebook had a low enough P/E to pass the screen.</p>\n<p>Here are the 43 S&amp;P 500 tech companies that trade below the tech sector’s forward P/E of 25.4:</p>\n<table>\n <thead>\n  <tr>\n   <th>COMPANY</th>\n   <th>TICKER</th>\n   <th>INDUSTRY</th>\n   <th>FORWARD P/E</th>\n   <th>FORWARD PRICE/SALES</th>\n   <th>ESTIMATED OPERATING MARGIN - 2020</th>\n   <th>EXPECTED SALES GROWTH - 2021</th>\n   <th>ESTIMATED SALES GROWTH - 2020</th>\n   <th>DIVIDEND YIELD</th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td>HEWLETT PACKARD ENTERPRISE CO.</td>\n   <td>HPE</td>\n   <td>COMPUTER PROCESSING HARDWARE</td>\n   <td>8.5</td>\n   <td>0.7</td>\n   <td>15.93%</td>\n   <td>2%</td>\n   <td>-6%</td>\n   <td>3.17%</td>\n  </tr>\n  <tr>\n   <td>DXC Technology Co.</td>\n   <td>DXC</td>\n   <td>Data Processing Services</td>\n   <td>9.1</td>\n   <td>0.4</td>\n   <td>11.83%</td>\n   <td>-6%</td>\n   <td>-8%</td>\n   <td>0.00%</td>\n  </tr>\n  <tr>\n   <td>HP Inc.</td>\n   <td>HPQ</td>\n   <td>Computer Processing Hardware</td>\n   <td>9.6</td>\n   <td>0.6</td>\n   <td>8.58%</td>\n   <td>5%</td>\n   <td>-2%</td>\n   <td>2.56%</td>\n  </tr>\n  <tr>\n   <td>International Business Machines Corp.</td>\n   <td>IBM</td>\n   <td>Information Technology Services</td>\n   <td>11.5</td>\n   <td>1.5</td>\n   <td>22.24%</td>\n   <td>1%</td>\n   <td>-5%</td>\n   <td>5.10%</td>\n  </tr>\n  <tr>\n   <td>Western Union Company</td>\n   <td>WU</td>\n   <td>Finance/Rental/Leasing</td>\n   <td>12.0</td>\n   <td>2.0</td>\n   <td>25.48%</td>\n   <td>6%</td>\n   <td>-8%</td>\n   <td>3.82%</td>\n  </tr>\n  <tr>\n   <td>Vontier Corp</td>\n   <td>VNT</td>\n   <td>Other Transportation</td>\n   <td>12.7</td>\n   <td>1.9</td>\n   <td>23.54%</td>\n   <td>2%</td>\n   <td>N/A</td>\n   <td>0.00%</td>\n  </tr>\n  <tr>\n   <td>Seagate Technology PLC</td>\n   <td>STX</td>\n   <td>Computer Peripherals</td>\n   <td>12.9</td>\n   <td>1.6</td>\n   <td>16.69%</td>\n   <td>2%</td>\n   <td>1%</td>\n   <td>3.58%</td>\n  </tr>\n  <tr>\n   <td>Intel Corp.</td>\n   <td>INTC</td>\n   <td>Semiconductors</td>\n   <td>13.1</td>\n   <td>3.5</td>\n   <td>46.12%</td>\n   <td>-7%</td>\n   <td>8%</td>\n   <td>2.23%</td>\n  </tr>\n  <tr>\n   <td>Xerox Holdings Corp.</td>\n   <td>XRX</td>\n   <td>Computer Peripherals</td>\n   <td>13.2</td>\n   <td>0.7</td>\n   <td>9.57%</td>\n   <td>1%</td>\n   <td>-23%</td>\n   <td>3.77%</td>\n  </tr>\n  <tr>\n   <td>NortonLifeLock Inc.</td>\n   <td>NLOK</td>\n   <td>Packaged Software</td>\n   <td>13.3</td>\n   <td>4.6</td>\n   <td>45.97%</td>\n   <td>5%</td>\n   <td>-17%</td>\n   <td>2.38%</td>\n  </tr>\n  <tr>\n   <td>Western Digital Corp.</td>\n   <td>WDC</td>\n   <td>Computer Peripherals</td>\n   <td>13.6</td>\n   <td>1.2</td>\n   <td>13.77%</td>\n   <td>5%</td>\n   <td>-1%</td>\n   <td>0.00%</td>\n  </tr>\n  <tr>\n   <td>Micron Technology Inc.</td>\n   <td>MU</td>\n   <td>Semiconductors</td>\n   <td>14.0</td>\n   <td>3.4</td>\n   <td>42.02%</td>\n   <td>24%</td>\n   <td>1%</td>\n   <td>0.00%</td>\n  </tr>\n  <tr>\n   <td>Cisco Systems Inc.</td>\n   <td>CSCO</td>\n   <td>Information Technology Services</td>\n   <td>14.5</td>\n   <td>4.0</td>\n   <td>31.85%</td>\n   <td>1%</td>\n   <td>-3%</td>\n   <td>3.06%</td>\n  </tr>\n  <tr>\n   <td>Juniper Networks Inc.</td>\n   <td>JNPR</td>\n   <td>Information Technology Services</td>\n   <td>14.9</td>\n   <td>1.8</td>\n   <td>14.68%</td>\n   <td>4%</td>\n   <td>0%</td>\n   <td>3.24%</td>\n  </tr>\n  <tr>\n   <td>Oracle Corp.</td>\n   <td>ORCL</td>\n   <td>Packaged Software</td>\n   <td>15.4</td>\n   <td>5.2</td>\n   <td>45.99%</td>\n   <td>3%</td>\n   <td>2%</td>\n   <td>1.77%</td>\n  </tr>\n  <tr>\n   <td>NetApp Inc.</td>\n   <td>NTAP</td>\n   <td>Computer Peripherals</td>\n   <td>15.5</td>\n   <td>2.5</td>\n   <td>20.87%</td>\n   <td>5%</td>\n   <td>-1%</td>\n   <td>2.88%</td>\n  </tr>\n  <tr>\n   <td>Qorvo Inc.</td>\n   <td>QRVO</td>\n   <td>Semiconductors</td>\n   <td>16.0</td>\n   <td>4.3</td>\n   <td>33.32%</td>\n   <td>12%</td>\n   <td>19%</td>\n   <td>0.00%</td>\n  </tr>\n  <tr>\n   <td>Broadcom Inc.</td>\n   <td>AVGO</td>\n   <td>Semiconductors</td>\n   <td>16.0</td>\n   <td>6.6</td>\n   <td>48.55%</td>\n   <td>11%</td>\n   <td>7%</td>\n   <td>3.29%</td>\n  </tr>\n  <tr>\n   <td>Skyworks Solutions Inc.</td>\n   <td>SWKS</td>\n   <td>Semiconductors</td>\n   <td>17.1</td>\n   <td>5.8</td>\n   <td>39.24%</td>\n   <td>32%</td>\n   <td>11%</td>\n   <td>1.19%</td>\n  </tr>\n  <tr>\n   <td>Qualcomm Inc.</td>\n   <td>QCOM</td>\n   <td>Telecommunications Equipment</td>\n   <td>17.3</td>\n   <td>4.6</td>\n   <td>34.20%</td>\n   <td>32%</td>\n   <td>20%</td>\n   <td>2.03%</td>\n  </tr>\n  <tr>\n   <td>Akamai Technologies Inc.</td>\n   <td>AKAM</td>\n   <td>Internet Software/Services</td>\n   <td>17.8</td>\n   <td>4.6</td>\n   <td>36.90%</td>\n   <td>7%</td>\n   <td>11%</td>\n   <td>0.00%</td>\n  </tr>\n  <tr>\n   <td>Applied Materials Inc.</td>\n   <td>AMAT</td>\n   <td>Industrial Machinery</td>\n   <td>18.3</td>\n   <td>4.7</td>\n   <td>27.95%</td>\n   <td>22%</td>\n   <td>19%</td>\n   <td>0.78%</td>\n  </tr>\n  <tr>\n   <td>F5 Networks Inc.</td>\n   <td>FFIV</td>\n   <td>Computer Communications</td>\n   <td>18.5</td>\n   <td>4.6</td>\n   <td>23.93%</td>\n   <td>8%</td>\n   <td>6%</td>\n   <td>0.00%</td>\n  </tr>\n  <tr>\n   <td>Cognizant Technology Solutions Corp. Class A</td>\n   <td>CTSH</td>\n   <td>Information Technology Services</td>\n   <td>19.2</td>\n   <td>2.3</td>\n   <td>17.33%</td>\n   <td>7%</td>\n   <td>-1%</td>\n   <td>1.26%</td>\n  </tr>\n  <tr>\n   <td>Microchip Technology Inc.</td>\n   <td>MCHP</td>\n   <td>Semiconductors</td>\n   <td>19.3</td>\n   <td>6.3</td>\n   <td>38.76%</td>\n   <td>10%</td>\n   <td>2%</td>\n   <td>1.10%</td>\n  </tr>\n  <tr>\n   <td>Corning Inc.</td>\n   <td>GLW</td>\n   <td>Electronic Components</td>\n   <td>19.9</td>\n   <td>2.3</td>\n   <td>24.82%</td>\n   <td>14%</td>\n   <td>-2%</td>\n   <td>2.46%</td>\n  </tr>\n  <tr>\n   <td>KLA Corp.</td>\n   <td>KLAC</td>\n   <td>Electronic Production Equipment</td>\n   <td>20.0</td>\n   <td>6.3</td>\n   <td>38.69%</td>\n   <td>10%</td>\n   <td>21%</td>\n   <td>1.27%</td>\n  </tr>\n  <tr>\n   <td>Lam Research Corp.</td>\n   <td>LRCX</td>\n   <td>Electronic Production Equipment</td>\n   <td>20.1</td>\n   <td>5.1</td>\n   <td>31.05%</td>\n   <td>19%</td>\n   <td>23%</td>\n   <td>1.00%</td>\n  </tr>\n  <tr>\n   <td>Motorola Solutions Inc.</td>\n   <td>MSI</td>\n   <td>Aerospace &amp; Defense</td>\n   <td>20.4</td>\n   <td>3.8</td>\n   <td>25.63%</td>\n   <td>8%</td>\n   <td>-6%</td>\n   <td>1.60%</td>\n  </tr>\n  <tr>\n   <td>Citrix Systems Inc.</td>\n   <td>CTXS</td>\n   <td>Packaged Software</td>\n   <td>20.7</td>\n   <td>4.8</td>\n   <td>25.60%</td>\n   <td>4%</td>\n   <td>8%</td>\n   <td>1.12%</td>\n  </tr>\n  <tr>\n   <td>TE Connectivity Ltd.</td>\n   <td>TEL</td>\n   <td>Electronic Components</td>\n   <td>21.9</td>\n   <td>3.1</td>\n   <td>20.96%</td>\n   <td>12%</td>\n   <td>-4%</td>\n   <td>1.48%</td>\n  </tr>\n  <tr>\n   <td>CDW Corp.</td>\n   <td>CDW</td>\n   <td>Information Technology Services</td>\n   <td>22.0</td>\n   <td>1.1</td>\n   <td>8.73%</td>\n   <td>6%</td>\n   <td>2%</td>\n   <td>1.02%</td>\n  </tr>\n  <tr>\n   <td>Electronic Arts Inc.</td>\n   <td>EA</td>\n   <td>Recreational Products</td>\n   <td>22.2</td>\n   <td>5.9</td>\n   <td>25.35%</td>\n   <td>7%</td>\n   <td>14%</td>\n   <td>0.52%</td>\n  </tr>\n  <tr>\n   <td>Teradyne Inc.</td>\n   <td>TER</td>\n   <td>Electronic Production Equipment</td>\n   <td>22.5</td>\n   <td>5.5</td>\n   <td>32.80%</td>\n   <td>6%</td>\n   <td>36%</td>\n   <td>0.37%</td>\n  </tr>\n  <tr>\n   <td>Fiserv Inc.</td>\n   <td>FISV</td>\n   <td>Data Processing Services</td>\n   <td>22.9</td>\n   <td>5.5</td>\n   <td>33.83%</td>\n   <td>9%</td>\n   <td>-4%</td>\n   <td>0.00%</td>\n  </tr>\n  <tr>\n   <td>Fidelity National Information Services Inc.</td>\n   <td>FIS</td>\n   <td>Data Processing Services</td>\n   <td>22.9</td>\n   <td>6.6</td>\n   <td>41.91%</td>\n   <td>9%</td>\n   <td>21%</td>\n   <td>1.07%</td>\n  </tr>\n  <tr>\n   <td>Fleetcor Technologies Inc.</td>\n   <td>FLT</td>\n   <td>Miscellaneous Commercial Services</td>\n   <td>22.9</td>\n   <td>9.0</td>\n   <td>55.51%</td>\n   <td>11%</td>\n   <td>-10%</td>\n   <td>0.00%</td>\n  </tr>\n  <tr>\n   <td>Flir Systems Inc.</td>\n   <td>FLIR</td>\n   <td>Aerospace &amp; Defense</td>\n   <td>23.1</td>\n   <td>3.7</td>\n   <td>23.00%</td>\n   <td>0%</td>\n   <td>2%</td>\n   <td>1.25%</td>\n  </tr>\n  <tr>\n   <td>Facebook Inc. Class A</td>\n   <td>FB</td>\n   <td>Internet Software/Services</td>\n   <td>23.2</td>\n   <td>7.0</td>\n   <td>45.99%</td>\n   <td>25%</td>\n   <td>22%</td>\n   <td>0.00%</td>\n  </tr>\n  <tr>\n   <td>Keysight Technologies Inc.</td>\n   <td>KEYS</td>\n   <td>Electronic Equipment/Instruments</td>\n   <td>23.4</td>\n   <td>5.1</td>\n   <td>25.57%</td>\n   <td>13%</td>\n   <td>1%</td>\n   <td>0.00%</td>\n  </tr>\n  <tr>\n   <td>Analog Devices Inc.</td>\n   <td>ADI</td>\n   <td>Semiconductors</td>\n   <td>23.9</td>\n   <td>8.2</td>\n   <td>43.13%</td>\n   <td>14%</td>\n   <td>-3%</td>\n   <td>1.88%</td>\n  </tr>\n  <tr>\n   <td>Activision Blizzard Inc.</td>\n   <td>ATVI</td>\n   <td>Recreational Products</td>\n   <td>25.0</td>\n   <td>8.3</td>\n   <td>41.32%</td>\n   <td>1%</td>\n   <td>32%</td>\n   <td>0.51%</td>\n  </tr>\n  <tr>\n   <td>Texas Instruments Inc.</td>\n   <td>TXN</td>\n   <td>Semiconductors</td>\n   <td>25.2</td>\n   <td>9.4</td>\n   <td>47.78%</td>\n   <td>15%</td>\n   <td>1%</td>\n   <td>2.41%</td>\n  </tr>\n </tbody>\n</table>\n<p>FactSet</p>\n<p>Scroll the table to see all the data, including sales growth estimates and dividend yields.</p>\n<p>A note about the data: The operating margin and sales growth figures for 2020 are marked “estimated” because many companies have fiscal years that don’t match the calendar. So the figures are based on consensus estimates for&nbsp;<i>calendar</i>&nbsp;2020 among analyst polled by FactSet. For Micron Technology Inc.,the 2020 sales growth figure is for the past four reported fiscal quarters through Dec. 3.</p>\n<p><b>The curious case of Facebook</b></p>\n<p>You might wonder about Facebook, which lives in both the value and growth worlds. Its forward P/E valuation of 23.2 is relatively low. But Facebook is very much a growth stock — sales increased 22% last year, and analysts expect even better revenue growth of 25% in 2021.</p>\n<p>Facebook trades for seven times the consensus forward sales estimate, compared to a forward price-to-sales estimate of 5.9 for the entire S&amp;P 500 tech sector. But that “high” price-to-sales ratio may not be so important because it is such a profitable company. Its 2020 operating margin of 50% is among the highest on the list.</p>\n<p>Cody Willard called Facebook a bargain, not only because of its low P/E valuation but because of&nbsp;the long-term growth path&nbsp;for its Oculus virtual-reality hardware and software.</p>\n<p>There are 16 companies on the list that are expected to produce double-digit increases in sales in 2021, including Skyworks Solutions Inc.&nbsp;and Qualcomm Inc..Both are expected to grow their revenues by 21% this year.</p>\n<p><b>‘Old tech’</b></p>\n<p>Oracle Corp.&nbsp;is an “old tech” company that can be considered a value stock, as it trades for only 15.4 times the consensus earnings estimate for the next 12 months among analysts polled by FactSet. The company reported better-than-expected results for its fiscal third quarter after the close March 10 and&nbsp;increased its quarterly dividend by a third. Then on March 11, the stock fell as much as 9%. That “sell the good news” reaction may not be much of a surprise, as the stock had risen 48% over the previous year through March 10.</p>\n<p>International Business Machines Corp.&nbsp;is one of the cheapest stocks on the list, based on its forward P/E ratio of 11.5. The stock was up 2% from a year earlier through the close March 10. It has an attractive dividend yield of 5.10% that is supported by strong free cash flow.</p>\n<p>Victoria Greene, a portfolio manager at G Squared Private Wealth in College Station, Texas,may have been a bit early&nbsp;when naming IBM as an excellent long-term play in June. But in a recent interview, she said she was still confident that there was a lot of upside for IBM “as a turnaround story and reinventing themselves,” in light of its July 2019 acquisition of Red Hat and the strength of its Watson artificial-intelligence software platform.</p>\n<p><b>Wall Street’s price targets</b></p>\n<p>Leaving the list of 43 tech value stocks in the same order, here’s a summary of opinion among analysts polled by FactSet:</p>\n<table>\n <thead>\n  <tr>\n   <th>COMPANY</th>\n   <th>TICKER</th>\n   <th>SHARE \"BUY\" RATINGS</th>\n   <th>SHARE NEUTRAL RATINGS</th>\n   <th>SHARE \"SELL\" RATINGS</th>\n   <th>CLOSING PRICE - MARCH 10</th>\n   <th>CONSENSUS PRICE TARGET</th>\n   <th>IMPLIED 12-MONTH UPSIDE POTENTIAL</th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td>HEWLETT PACKARD ENTERPRISE CO.</td>\n   <td>HPE</td>\n   <td>33%</td>\n   <td>57%</td>\n   <td>10%</td>\n   <td>$15.15</td>\n   <td>$15.46</td>\n   <td>2%</td>\n  </tr>\n  <tr>\n   <td>DXC Technology Co.</td>\n   <td>DXC</td>\n   <td>29%</td>\n   <td>71%</td>\n   <td>0%</td>\n   <td>$29.00</td>\n   <td>$30.43</td>\n   <td>5%</td>\n  </tr>\n  <tr>\n   <td>HP Inc.</td>\n   <td>HPQ</td>\n   <td>39%</td>\n   <td>39%</td>\n   <td>22%</td>\n   <td>$30.26</td>\n   <td>$30.63</td>\n   <td>1%</td>\n  </tr>\n  <tr>\n   <td>International Business Machines Corp.</td>\n   <td>IBM</td>\n   <td>31%</td>\n   <td>56%</td>\n   <td>13%</td>\n   <td>$127.87</td>\n   <td>$136.93</td>\n   <td>7%</td>\n  </tr>\n  <tr>\n   <td>Western Union Company</td>\n   <td>WU</td>\n   <td>18%</td>\n   <td>59%</td>\n   <td>23%</td>\n   <td>$24.60</td>\n   <td>$25.14</td>\n   <td>2%</td>\n  </tr>\n  <tr>\n   <td>Vontier Corp</td>\n   <td>VNT</td>\n   <td>73%</td>\n   <td>27%</td>\n   <td>0%</td>\n   <td>$30.94</td>\n   <td>$39.56</td>\n   <td>28%</td>\n  </tr>\n  <tr>\n   <td>Seagate Technology PLC</td>\n   <td>STX</td>\n   <td>38%</td>\n   <td>48%</td>\n   <td>14%</td>\n   <td>$74.93</td>\n   <td>$74.83</td>\n   <td>0%</td>\n  </tr>\n  <tr>\n   <td>Intel Corp.</td>\n   <td>INTC</td>\n   <td>37%</td>\n   <td>39%</td>\n   <td>24%</td>\n   <td>$62.25</td>\n   <td>$63.93</td>\n   <td>3%</td>\n  </tr>\n  <tr>\n   <td>Xerox Holdings Corp.</td>\n   <td>XRX</td>\n   <td>0%</td>\n   <td>38%</td>\n   <td>62%</td>\n   <td>$26.53</td>\n   <td>$18.00</td>\n   <td>-32%</td>\n  </tr>\n  <tr>\n   <td>NortonLifeLock Inc.</td>\n   <td>NLOK</td>\n   <td>50%</td>\n   <td>50%</td>\n   <td>0%</td>\n   <td>$21.01</td>\n   <td>$25.88</td>\n   <td>23%</td>\n  </tr>\n  <tr>\n   <td>Western Digital Corp.</td>\n   <td>WDC</td>\n   <td>66%</td>\n   <td>31%</td>\n   <td>3%</td>\n   <td>$66.58</td>\n   <td>$71.35</td>\n   <td>7%</td>\n  </tr>\n  <tr>\n   <td>Micron Technology Inc.</td>\n   <td>MU</td>\n   <td>82%</td>\n   <td>18%</td>\n   <td>0%</td>\n   <td>$85.41</td>\n   <td>$112.26</td>\n   <td>31%</td>\n  </tr>\n  <tr>\n   <td>Cisco Systems Inc.</td>\n   <td>CSCO</td>\n   <td>46%</td>\n   <td>54%</td>\n   <td>0%</td>\n   <td>$48.29</td>\n   <td>$51.90</td>\n   <td>7%</td>\n  </tr>\n  <tr>\n   <td>Juniper Networks Inc.</td>\n   <td>JNPR</td>\n   <td>24%</td>\n   <td>57%</td>\n   <td>19%</td>\n   <td>$24.69</td>\n   <td>$25.05</td>\n   <td>1%</td>\n  </tr>\n  <tr>\n   <td>Oracle Corp.</td>\n   <td>ORCL</td>\n   <td>37%</td>\n   <td>56%</td>\n   <td>7%</td>\n   <td>$72.12</td>\n   <td>$72.35</td>\n   <td>0%</td>\n  </tr>\n  <tr>\n   <td>NetApp Inc.</td>\n   <td>NTAP</td>\n   <td>46%</td>\n   <td>46%</td>\n   <td>8%</td>\n   <td>$66.66</td>\n   <td>$74.77</td>\n   <td>12%</td>\n  </tr>\n  <tr>\n   <td>Qorvo Inc.</td>\n   <td>QRVO</td>\n   <td>65%</td>\n   <td>35%</td>\n   <td>0%</td>\n   <td>$165.37</td>\n   <td>$196.52</td>\n   <td>19%</td>\n  </tr>\n  <tr>\n   <td>Broadcom Inc.</td>\n   <td>AVGO</td>\n   <td>81%</td>\n   <td>16%</td>\n   <td>3%</td>\n   <td>$437.59</td>\n   <td>$512.83</td>\n   <td>17%</td>\n  </tr>\n  <tr>\n   <td>Skyworks Solutions Inc.</td>\n   <td>SWKS</td>\n   <td>57%</td>\n   <td>43%</td>\n   <td>0%</td>\n   <td>$167.66</td>\n   <td>$202.44</td>\n   <td>21%</td>\n  </tr>\n  <tr>\n   <td>Qualcomm Inc.</td>\n   <td>QCOM</td>\n   <td>70%</td>\n   <td>27%</td>\n   <td>3%</td>\n   <td>$127.87</td>\n   <td>$171.90</td>\n   <td>34%</td>\n  </tr>\n  <tr>\n   <td>Akamai Technologies Inc.</td>\n   <td>AKAM</td>\n   <td>67%</td>\n   <td>28%</td>\n   <td>5%</td>\n   <td>$96.36</td>\n   <td>$123.69</td>\n   <td>28%</td>\n  </tr>\n  <tr>\n   <td>Applied Materials Inc.</td>\n   <td>AMAT</td>\n   <td>84%</td>\n   <td>16%</td>\n   <td>0%</td>\n   <td>$112.68</td>\n   <td>$136.83</td>\n   <td>21%</td>\n  </tr>\n  <tr>\n   <td>F5 Networks Inc.</td>\n   <td>FFIV</td>\n   <td>50%</td>\n   <td>50%</td>\n   <td>0%</td>\n   <td>$191.70</td>\n   <td>$220.13</td>\n   <td>15%</td>\n  </tr>\n  <tr>\n   <td>Cognizant Technology Solutions Corp. Class A</td>\n   <td>CTSH</td>\n   <td>48%</td>\n   <td>42%</td>\n   <td>10%</td>\n   <td>$76.02</td>\n   <td>$85.19</td>\n   <td>12%</td>\n  </tr>\n  <tr>\n   <td>Microchip Technology Inc.</td>\n   <td>MCHP</td>\n   <td>79%</td>\n   <td>21%</td>\n   <td>0%</td>\n   <td>$141.32</td>\n   <td>$170.52</td>\n   <td>21%</td>\n  </tr>\n  <tr>\n   <td>Corning Inc.</td>\n   <td>GLW</td>\n   <td>57%</td>\n   <td>43%</td>\n   <td>0%</td>\n   <td>$38.97</td>\n   <td>$41.29</td>\n   <td>6%</td>\n  </tr>\n  <tr>\n   <td>KLA Corp.</td>\n   <td>KLAC</td>\n   <td>45%</td>\n   <td>55%</td>\n   <td>0%</td>\n   <td>$283.45</td>\n   <td>$320.12</td>\n   <td>13%</td>\n  </tr>\n  <tr>\n   <td>Lam Research Corp.</td>\n   <td>LRCX</td>\n   <td>76%</td>\n   <td>20%</td>\n   <td>4%</td>\n   <td>$518.70</td>\n   <td>$593.68</td>\n   <td>14%</td>\n  </tr>\n  <tr>\n   <td>Motorola Solutions Inc.</td>\n   <td>MSI</td>\n   <td>75%</td>\n   <td>25%</td>\n   <td>0%</td>\n   <td>$177.76</td>\n   <td>$204.78</td>\n   <td>15%</td>\n  </tr>\n  <tr>\n   <td>Citrix Systems Inc.</td>\n   <td>CTXS</td>\n   <td>53%</td>\n   <td>47%</td>\n   <td>0%</td>\n   <td>$131.78</td>\n   <td>$159.23</td>\n   <td>21%</td>\n  </tr>\n  <tr>\n   <td>TE Connectivity Ltd.</td>\n   <td>TEL</td>\n   <td>60%</td>\n   <td>35%</td>\n   <td>5%</td>\n   <td>$130.09</td>\n   <td>$136.50</td>\n   <td>5%</td>\n  </tr>\n  <tr>\n   <td>CDW Corp.</td>\n   <td>CDW</td>\n   <td>73%</td>\n   <td>18%</td>\n   <td>9%</td>\n   <td>$156.44</td>\n   <td>$169.56</td>\n   <td>8%</td>\n  </tr>\n  <tr>\n   <td>Electronic Arts Inc.</td>\n   <td>EA</td>\n   <td>62%</td>\n   <td>38%</td>\n   <td>0%</td>\n   <td>$130.12</td>\n   <td>$158.83</td>\n   <td>22%</td>\n  </tr>\n  <tr>\n   <td>Teradyne Inc.</td>\n   <td>TER</td>\n   <td>61%</td>\n   <td>33%</td>\n   <td>6%</td>\n   <td>$108.91</td>\n   <td>$136.89</td>\n   <td>26%</td>\n  </tr>\n  <tr>\n   <td>Fiserv Inc.</td>\n   <td>FISV</td>\n   <td>86%</td>\n   <td>11%</td>\n   <td>3%</td>\n   <td>$123.86</td>\n   <td>$136.55</td>\n   <td>10%</td>\n  </tr>\n  <tr>\n   <td>Fidelity National Information Services Inc.</td>\n   <td>FIS</td>\n   <td>74%</td>\n   <td>26%</td>\n   <td>0%</td>\n   <td>$145.52</td>\n   <td>$160.44</td>\n   <td>10%</td>\n  </tr>\n  <tr>\n   <td>Fleetcor Technologies Inc.</td>\n   <td>FLT</td>\n   <td>62%</td>\n   <td>38%</td>\n   <td>0%</td>\n   <td>$285.37</td>\n   <td>$299.16</td>\n   <td>5%</td>\n  </tr>\n  <tr>\n   <td>Flir Systems Inc.</td>\n   <td>FLIR</td>\n   <td>0%</td>\n   <td>100%</td>\n   <td>0%</td>\n   <td>$54.59</td>\n   <td>$55.17</td>\n   <td>1%</td>\n  </tr>\n  <tr>\n   <td>Facebook Inc. Class A</td>\n   <td>FB</td>\n   <td>86%</td>\n   <td>10%</td>\n   <td>4%</td>\n   <td>$264.90</td>\n   <td>$340.40</td>\n   <td>29%</td>\n  </tr>\n  <tr>\n   <td>Keysight Technologies Inc.</td>\n   <td>KEYS</td>\n   <td>85%</td>\n   <td>15%</td>\n   <td>0%</td>\n   <td>$135.28</td>\n   <td>$164.77</td>\n   <td>22%</td>\n  </tr>\n  <tr>\n   <td>Analog Devices Inc.</td>\n   <td>ADI</td>\n   <td>83%</td>\n   <td>17%</td>\n   <td>0%</td>\n   <td>$147.11</td>\n   <td>$181.55</td>\n   <td>23%</td>\n  </tr>\n  <tr>\n   <td>Activision Blizzard Inc.</td>\n   <td>ATVI</td>\n   <td>82%</td>\n   <td>15%</td>\n   <td>3%</td>\n   <td>$91.31</td>\n   <td>$113.32</td>\n   <td>24%</td>\n  </tr>\n  <tr>\n   <td>Texas Instruments Inc.</td>\n   <td>TXN</td>\n   <td>43%</td>\n   <td>40%</td>\n   <td>17%</td>\n   <td>$169.42</td>\n   <td>$184.80</td>\n   <td>9%</td>\n  </tr>\n </tbody>\n</table>\n<p>FactSet</p>\n<p>Scroll the table to the right to see the price targets.</p>\n<p>The analysts see double-digit upside potential for 25 of the 43 stocks over the next 12 months, with Qualcomm in the lead. Among the analysts polled by FactSet, 70% rate Qualcomm a “buy” or the equivalent. And the consensus price target implies 34% upside for the stock.</p>\n<p>The listed stock with the highest percentage of “buy” or equivalent ratings is Facebook, at 86%. The analysts expect the stock to rise 29% over the next year.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Don’t be fooled by the ‘value’ tag on these tech stocks. Many can provide plenty of growth too</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDon’t be fooled by the ‘value’ tag on these tech stocks. Many can provide plenty of growth too\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-12 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/dont-be-fooled-by-the-value-tag-on-these-tech-stocks-many-can-provide-plenty-of-growth-too-11615484802?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Facebook, Oracle and Micron Technology are reasonably valued when considering the outlook for their sales growth.\nWith another round of federal stimulus on the way and expectations for solid growth ...</p>\n\n<a href=\"https://www.marketwatch.com/story/dont-be-fooled-by-the-value-tag-on-these-tech-stocks-many-can-provide-plenty-of-growth-too-11615484802?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯","TWTR":"Twitter",".IXIC":"NASDAQ Composite","ORCL":"甲骨文",".SPX":"S&P 500 Index","INTC":"英特尔"},"source_url":"https://www.marketwatch.com/story/dont-be-fooled-by-the-value-tag-on-these-tech-stocks-many-can-provide-plenty-of-growth-too-11615484802?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1155506399","content_text":"Facebook, Oracle and Micron Technology are reasonably valued when considering the outlook for their sales growth.\nWith another round of federal stimulus on the way and expectations for solid growth for the U.S. economy this year, value stocks have been rallying. Stocks with low valuations tend to do well during economic growth phases.\nMark DeCambre underlined the value rallyby pointing out that the Dow Jones Industrial Average ended at a record high Dec. 10, while the Nasdaq Composite Index was still in a correction.\nBut what about tech stocks? There’s plenty of value there too, as you can see in the screen below.\nEconomists polled by MarketWatch expect the U.S. economy to expand by 6% in 2021. Yes, that’s coming off a 3.5% contraction in 2020, according to the latest estimate from the Bureau of Economic Analysis. But the 2021 growth rate would be the fastest since 1984, according to World Bank data.\nTech value stock screen\nThere are several definitions of value stocks, but generally they are those that trade at lower valuations to earnings and typically grow their sales at a slower pace. That said, an individual value stock might also be considered a growth stock. This is illustrated by the Russell indexes.\nThe Russell 1000 Index is made up of the 1,000 largest publicly traded U.S. companies by market capitalization and is reconstituted each year in June. Selected from the Russell 1000 are the Russell 1000 Value Index,which has 849 stocks, and the Russell 1000 Growth Index,which has 453 stocks. The groups overlap, with 291 stocks in both. You can read how FTSE Russell describes the makeup of its indexeshere.\nSo an easy way to play value at this time is to buy shares of an exchange traded fund that tracks the Russell 1000 Value Index,such as the iShares Russell 1000 Value ETF or the Vanguard Russell 1000 Value ETF.As always, do your own research on any investment you consider to make an informed decisions.\nFor a large-cap technology value screen, we started with the information technology sector of the S&P 500 Index.Here’s how this sector’s weighted aggregate forward price-to-earnings ratio has increased over the past five years:\n(FACTSET)\nThe sector’s forward P/E his risen to 25.4.\nThis doesn’t mean “expensive” tech stocks can’t be excellent investments. Salesforce.com was trading at a forward P/E of 68.7 five years ago, and the stock has nearly tripled since then.\nGetting back to the S&P 500 tech value screen, we then added tech-oriented stocks in the communications services sector, including videogame developers and Facebook Inc.,Alphabet Inc.,Netflix Inc. and Twitter Inc..That brought the list up to 82 stocks. Two of the videogame developers made the cut, but among the four companies named above, only Facebook had a low enough P/E to pass the screen.\nHere are the 43 S&P 500 tech companies that trade below the tech sector’s forward P/E of 25.4:\n\n\n\nCOMPANY\nTICKER\nINDUSTRY\nFORWARD P/E\nFORWARD PRICE/SALES\nESTIMATED OPERATING MARGIN - 2020\nEXPECTED SALES GROWTH - 2021\nESTIMATED SALES GROWTH - 2020\nDIVIDEND YIELD\n\n\n\n\nHEWLETT PACKARD ENTERPRISE CO.\nHPE\nCOMPUTER PROCESSING HARDWARE\n8.5\n0.7\n15.93%\n2%\n-6%\n3.17%\n\n\nDXC Technology Co.\nDXC\nData Processing Services\n9.1\n0.4\n11.83%\n-6%\n-8%\n0.00%\n\n\nHP Inc.\nHPQ\nComputer Processing Hardware\n9.6\n0.6\n8.58%\n5%\n-2%\n2.56%\n\n\nInternational Business Machines Corp.\nIBM\nInformation Technology Services\n11.5\n1.5\n22.24%\n1%\n-5%\n5.10%\n\n\nWestern Union Company\nWU\nFinance/Rental/Leasing\n12.0\n2.0\n25.48%\n6%\n-8%\n3.82%\n\n\nVontier Corp\nVNT\nOther Transportation\n12.7\n1.9\n23.54%\n2%\nN/A\n0.00%\n\n\nSeagate Technology PLC\nSTX\nComputer Peripherals\n12.9\n1.6\n16.69%\n2%\n1%\n3.58%\n\n\nIntel Corp.\nINTC\nSemiconductors\n13.1\n3.5\n46.12%\n-7%\n8%\n2.23%\n\n\nXerox Holdings Corp.\nXRX\nComputer Peripherals\n13.2\n0.7\n9.57%\n1%\n-23%\n3.77%\n\n\nNortonLifeLock Inc.\nNLOK\nPackaged Software\n13.3\n4.6\n45.97%\n5%\n-17%\n2.38%\n\n\nWestern Digital Corp.\nWDC\nComputer Peripherals\n13.6\n1.2\n13.77%\n5%\n-1%\n0.00%\n\n\nMicron Technology Inc.\nMU\nSemiconductors\n14.0\n3.4\n42.02%\n24%\n1%\n0.00%\n\n\nCisco Systems Inc.\nCSCO\nInformation Technology Services\n14.5\n4.0\n31.85%\n1%\n-3%\n3.06%\n\n\nJuniper Networks Inc.\nJNPR\nInformation Technology Services\n14.9\n1.8\n14.68%\n4%\n0%\n3.24%\n\n\nOracle Corp.\nORCL\nPackaged Software\n15.4\n5.2\n45.99%\n3%\n2%\n1.77%\n\n\nNetApp Inc.\nNTAP\nComputer Peripherals\n15.5\n2.5\n20.87%\n5%\n-1%\n2.88%\n\n\nQorvo Inc.\nQRVO\nSemiconductors\n16.0\n4.3\n33.32%\n12%\n19%\n0.00%\n\n\nBroadcom Inc.\nAVGO\nSemiconductors\n16.0\n6.6\n48.55%\n11%\n7%\n3.29%\n\n\nSkyworks Solutions Inc.\nSWKS\nSemiconductors\n17.1\n5.8\n39.24%\n32%\n11%\n1.19%\n\n\nQualcomm Inc.\nQCOM\nTelecommunications Equipment\n17.3\n4.6\n34.20%\n32%\n20%\n2.03%\n\n\nAkamai Technologies Inc.\nAKAM\nInternet Software/Services\n17.8\n4.6\n36.90%\n7%\n11%\n0.00%\n\n\nApplied Materials Inc.\nAMAT\nIndustrial Machinery\n18.3\n4.7\n27.95%\n22%\n19%\n0.78%\n\n\nF5 Networks Inc.\nFFIV\nComputer Communications\n18.5\n4.6\n23.93%\n8%\n6%\n0.00%\n\n\nCognizant Technology Solutions Corp. Class A\nCTSH\nInformation Technology Services\n19.2\n2.3\n17.33%\n7%\n-1%\n1.26%\n\n\nMicrochip Technology Inc.\nMCHP\nSemiconductors\n19.3\n6.3\n38.76%\n10%\n2%\n1.10%\n\n\nCorning Inc.\nGLW\nElectronic Components\n19.9\n2.3\n24.82%\n14%\n-2%\n2.46%\n\n\nKLA Corp.\nKLAC\nElectronic Production Equipment\n20.0\n6.3\n38.69%\n10%\n21%\n1.27%\n\n\nLam Research Corp.\nLRCX\nElectronic Production Equipment\n20.1\n5.1\n31.05%\n19%\n23%\n1.00%\n\n\nMotorola Solutions Inc.\nMSI\nAerospace & Defense\n20.4\n3.8\n25.63%\n8%\n-6%\n1.60%\n\n\nCitrix Systems Inc.\nCTXS\nPackaged Software\n20.7\n4.8\n25.60%\n4%\n8%\n1.12%\n\n\nTE Connectivity Ltd.\nTEL\nElectronic Components\n21.9\n3.1\n20.96%\n12%\n-4%\n1.48%\n\n\nCDW Corp.\nCDW\nInformation Technology Services\n22.0\n1.1\n8.73%\n6%\n2%\n1.02%\n\n\nElectronic Arts Inc.\nEA\nRecreational Products\n22.2\n5.9\n25.35%\n7%\n14%\n0.52%\n\n\nTeradyne Inc.\nTER\nElectronic Production Equipment\n22.5\n5.5\n32.80%\n6%\n36%\n0.37%\n\n\nFiserv Inc.\nFISV\nData Processing Services\n22.9\n5.5\n33.83%\n9%\n-4%\n0.00%\n\n\nFidelity National Information Services Inc.\nFIS\nData Processing Services\n22.9\n6.6\n41.91%\n9%\n21%\n1.07%\n\n\nFleetcor Technologies Inc.\nFLT\nMiscellaneous Commercial Services\n22.9\n9.0\n55.51%\n11%\n-10%\n0.00%\n\n\nFlir Systems Inc.\nFLIR\nAerospace & Defense\n23.1\n3.7\n23.00%\n0%\n2%\n1.25%\n\n\nFacebook Inc. Class A\nFB\nInternet Software/Services\n23.2\n7.0\n45.99%\n25%\n22%\n0.00%\n\n\nKeysight Technologies Inc.\nKEYS\nElectronic Equipment/Instruments\n23.4\n5.1\n25.57%\n13%\n1%\n0.00%\n\n\nAnalog Devices Inc.\nADI\nSemiconductors\n23.9\n8.2\n43.13%\n14%\n-3%\n1.88%\n\n\nActivision Blizzard Inc.\nATVI\nRecreational Products\n25.0\n8.3\n41.32%\n1%\n32%\n0.51%\n\n\nTexas Instruments Inc.\nTXN\nSemiconductors\n25.2\n9.4\n47.78%\n15%\n1%\n2.41%\n\n\n\nFactSet\nScroll the table to see all the data, including sales growth estimates and dividend yields.\nA note about the data: The operating margin and sales growth figures for 2020 are marked “estimated” because many companies have fiscal years that don’t match the calendar. So the figures are based on consensus estimates for calendar 2020 among analyst polled by FactSet. For Micron Technology Inc.,the 2020 sales growth figure is for the past four reported fiscal quarters through Dec. 3.\nThe curious case of Facebook\nYou might wonder about Facebook, which lives in both the value and growth worlds. Its forward P/E valuation of 23.2 is relatively low. But Facebook is very much a growth stock — sales increased 22% last year, and analysts expect even better revenue growth of 25% in 2021.\nFacebook trades for seven times the consensus forward sales estimate, compared to a forward price-to-sales estimate of 5.9 for the entire S&P 500 tech sector. But that “high” price-to-sales ratio may not be so important because it is such a profitable company. Its 2020 operating margin of 50% is among the highest on the list.\nCody Willard called Facebook a bargain, not only because of its low P/E valuation but because of the long-term growth path for its Oculus virtual-reality hardware and software.\nThere are 16 companies on the list that are expected to produce double-digit increases in sales in 2021, including Skyworks Solutions Inc. and Qualcomm Inc..Both are expected to grow their revenues by 21% this year.\n‘Old tech’\nOracle Corp. is an “old tech” company that can be considered a value stock, as it trades for only 15.4 times the consensus earnings estimate for the next 12 months among analysts polled by FactSet. The company reported better-than-expected results for its fiscal third quarter after the close March 10 and increased its quarterly dividend by a third. Then on March 11, the stock fell as much as 9%. That “sell the good news” reaction may not be much of a surprise, as the stock had risen 48% over the previous year through March 10.\nInternational Business Machines Corp. is one of the cheapest stocks on the list, based on its forward P/E ratio of 11.5. The stock was up 2% from a year earlier through the close March 10. It has an attractive dividend yield of 5.10% that is supported by strong free cash flow.\nVictoria Greene, a portfolio manager at G Squared Private Wealth in College Station, Texas,may have been a bit early when naming IBM as an excellent long-term play in June. But in a recent interview, she said she was still confident that there was a lot of upside for IBM “as a turnaround story and reinventing themselves,” in light of its July 2019 acquisition of Red Hat and the strength of its Watson artificial-intelligence software platform.\nWall Street’s price targets\nLeaving the list of 43 tech value stocks in the same order, here’s a summary of opinion among analysts polled by FactSet:\n\n\n\nCOMPANY\nTICKER\nSHARE \"BUY\" RATINGS\nSHARE NEUTRAL RATINGS\nSHARE \"SELL\" RATINGS\nCLOSING PRICE - MARCH 10\nCONSENSUS PRICE TARGET\nIMPLIED 12-MONTH UPSIDE POTENTIAL\n\n\n\n\nHEWLETT PACKARD ENTERPRISE CO.\nHPE\n33%\n57%\n10%\n$15.15\n$15.46\n2%\n\n\nDXC Technology Co.\nDXC\n29%\n71%\n0%\n$29.00\n$30.43\n5%\n\n\nHP Inc.\nHPQ\n39%\n39%\n22%\n$30.26\n$30.63\n1%\n\n\nInternational Business Machines Corp.\nIBM\n31%\n56%\n13%\n$127.87\n$136.93\n7%\n\n\nWestern Union Company\nWU\n18%\n59%\n23%\n$24.60\n$25.14\n2%\n\n\nVontier Corp\nVNT\n73%\n27%\n0%\n$30.94\n$39.56\n28%\n\n\nSeagate Technology PLC\nSTX\n38%\n48%\n14%\n$74.93\n$74.83\n0%\n\n\nIntel Corp.\nINTC\n37%\n39%\n24%\n$62.25\n$63.93\n3%\n\n\nXerox Holdings Corp.\nXRX\n0%\n38%\n62%\n$26.53\n$18.00\n-32%\n\n\nNortonLifeLock Inc.\nNLOK\n50%\n50%\n0%\n$21.01\n$25.88\n23%\n\n\nWestern Digital Corp.\nWDC\n66%\n31%\n3%\n$66.58\n$71.35\n7%\n\n\nMicron Technology Inc.\nMU\n82%\n18%\n0%\n$85.41\n$112.26\n31%\n\n\nCisco Systems Inc.\nCSCO\n46%\n54%\n0%\n$48.29\n$51.90\n7%\n\n\nJuniper Networks Inc.\nJNPR\n24%\n57%\n19%\n$24.69\n$25.05\n1%\n\n\nOracle Corp.\nORCL\n37%\n56%\n7%\n$72.12\n$72.35\n0%\n\n\nNetApp Inc.\nNTAP\n46%\n46%\n8%\n$66.66\n$74.77\n12%\n\n\nQorvo Inc.\nQRVO\n65%\n35%\n0%\n$165.37\n$196.52\n19%\n\n\nBroadcom Inc.\nAVGO\n81%\n16%\n3%\n$437.59\n$512.83\n17%\n\n\nSkyworks Solutions Inc.\nSWKS\n57%\n43%\n0%\n$167.66\n$202.44\n21%\n\n\nQualcomm Inc.\nQCOM\n70%\n27%\n3%\n$127.87\n$171.90\n34%\n\n\nAkamai Technologies Inc.\nAKAM\n67%\n28%\n5%\n$96.36\n$123.69\n28%\n\n\nApplied Materials Inc.\nAMAT\n84%\n16%\n0%\n$112.68\n$136.83\n21%\n\n\nF5 Networks Inc.\nFFIV\n50%\n50%\n0%\n$191.70\n$220.13\n15%\n\n\nCognizant Technology Solutions Corp. Class A\nCTSH\n48%\n42%\n10%\n$76.02\n$85.19\n12%\n\n\nMicrochip Technology Inc.\nMCHP\n79%\n21%\n0%\n$141.32\n$170.52\n21%\n\n\nCorning Inc.\nGLW\n57%\n43%\n0%\n$38.97\n$41.29\n6%\n\n\nKLA Corp.\nKLAC\n45%\n55%\n0%\n$283.45\n$320.12\n13%\n\n\nLam Research Corp.\nLRCX\n76%\n20%\n4%\n$518.70\n$593.68\n14%\n\n\nMotorola Solutions Inc.\nMSI\n75%\n25%\n0%\n$177.76\n$204.78\n15%\n\n\nCitrix Systems Inc.\nCTXS\n53%\n47%\n0%\n$131.78\n$159.23\n21%\n\n\nTE Connectivity Ltd.\nTEL\n60%\n35%\n5%\n$130.09\n$136.50\n5%\n\n\nCDW Corp.\nCDW\n73%\n18%\n9%\n$156.44\n$169.56\n8%\n\n\nElectronic Arts Inc.\nEA\n62%\n38%\n0%\n$130.12\n$158.83\n22%\n\n\nTeradyne Inc.\nTER\n61%\n33%\n6%\n$108.91\n$136.89\n26%\n\n\nFiserv Inc.\nFISV\n86%\n11%\n3%\n$123.86\n$136.55\n10%\n\n\nFidelity National Information Services Inc.\nFIS\n74%\n26%\n0%\n$145.52\n$160.44\n10%\n\n\nFleetcor Technologies Inc.\nFLT\n62%\n38%\n0%\n$285.37\n$299.16\n5%\n\n\nFlir Systems Inc.\nFLIR\n0%\n100%\n0%\n$54.59\n$55.17\n1%\n\n\nFacebook Inc. Class A\nFB\n86%\n10%\n4%\n$264.90\n$340.40\n29%\n\n\nKeysight Technologies Inc.\nKEYS\n85%\n15%\n0%\n$135.28\n$164.77\n22%\n\n\nAnalog Devices Inc.\nADI\n83%\n17%\n0%\n$147.11\n$181.55\n23%\n\n\nActivision Blizzard Inc.\nATVI\n82%\n15%\n3%\n$91.31\n$113.32\n24%\n\n\nTexas Instruments Inc.\nTXN\n43%\n40%\n17%\n$169.42\n$184.80\n9%\n\n\n\nFactSet\nScroll the table to the right to see the price targets.\nThe analysts see double-digit upside potential for 25 of the 43 stocks over the next 12 months, with Qualcomm in the lead. Among the analysts polled by FactSet, 70% rate Qualcomm a “buy” or the equivalent. And the consensus price target implies 34% upside for the stock.\nThe listed stock with the highest percentage of “buy” or equivalent ratings is Facebook, at 86%. The analysts expect the stock to rise 29% over the next year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":321669546,"gmtCreate":1615429632285,"gmtModify":1704782657766,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SE\">$Sea Ltd(SE)$</a>Was a little disappointed that we didn’t hold the slope up yesterday but I guess it would be good to spend more time in consolidation mode. It could be difficult to see but will be healthier in the long run. Hoping for more sustained upside action in the months to come!","listText":"<a href=\"https://laohu8.com/S/SE\">$Sea Ltd(SE)$</a>Was a little disappointed that we didn’t hold the slope up yesterday but I guess it would be good to spend more time in consolidation mode. It could be difficult to see but will be healthier in the long run. Hoping for more sustained upside action in the months to come!","text":"$Sea Ltd(SE)$Was a little disappointed that we didn’t hold the slope up yesterday but I guess it would be good to spend more time in consolidation mode. It could be difficult to see but will be healthier in the long run. Hoping for more sustained upside action in the months to come!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/321669546","isVote":1,"tweetType":1,"viewCount":321,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":323320685,"gmtCreate":1615303982947,"gmtModify":1704780943187,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SE\">$Sea Ltd(SE)$</a>My only regret is not buying when Shopee launched in Singapore a few years ago. They’re actually doing quite well in terms of public sentiment and I think they’ll do well compared to direct competitors&nbsp;","listText":"<a href=\"https://laohu8.com/S/SE\">$Sea Ltd(SE)$</a>My only regret is not buying when Shopee launched in Singapore a few years ago. They’re actually doing quite well in terms of public sentiment and I think they’ll do well compared to direct competitors&nbsp;","text":"$Sea Ltd(SE)$My only regret is not buying when Shopee launched in Singapore a few years ago. They’re actually doing quite well in terms of public sentiment and I think they’ll do well compared to direct competitors","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/323320685","isVote":1,"tweetType":1,"viewCount":69,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":323366601,"gmtCreate":1615303798003,"gmtModify":1704780934099,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Go J&amp;J!","listText":"Go J&amp;J!","text":"Go J&J!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/323366601","repostId":"1117128744","repostType":4,"repost":{"id":"1117128744","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1615298116,"share":"https://ttm.financial/m/news/1117128744?lang=&edition=fundamental","pubTime":"2021-03-09 21:55","market":"us","language":"en","title":"J&J 'under stress' to meet EU second-quarter vaccine supply goal - source","url":"https://stock-news.laohu8.com/highlight/detail?id=1117128744","media":"Reuters","summary":"Johnson & Johnson has told the European Union it is facing supply issues that may complicate plans t","content":"<p>Johnson &amp; Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its COVID-19 vaccine to the bloc in the second quarter of the year, an EU official told Reuters.</p><p>Any delay would be a further blow to EU’s vaccination plans, which have been hampered by bumpy supplies from other vaccine makers and a slow rollout of shots in many member states.</p><p>J&amp;J told the EU last week that issues with the supply of vaccine ingredients and equipment meant it was “under stress” to meet the goal of delivering 55 million doses by the end of June, the EU official - who is directly involved in confidential talks with the U.S. company - told Reuters on condition of anonymity.</p><p>The official added the company had said it was not impossible to meet the goal, but that it showed caution.</p><p>J&amp;J’s vaccine, which requires only one dose for protection, is expected to be approved on March 11 for use in the EU by the bloc’s regulator. EU officials have said deliveries could start in April.</p><p>The company has committed to deliver 200 million doses of its vaccine to the bloc this year.</p><p>“Aligned with our agreement, we expect to begin supplying our commitment of 200 million doses to the European Union in the second quarter of 2021,” J&amp;J said in a statement, declining to comment on possible delays or the second-quarter target.</p><p>J&amp;J began rolling out its vaccine in the United States this month, with a target of delivering 100 million doses by the end of May, but has nearly halved its delivery forecasts for March to 20 million doses as it ramps up new manufacturing facilities.</p><p>A spokesman for the European Commission declined to comment on J&amp;J’s delivery schedules. The Commission coordinates EU talks with vaccine makers and has come under fire for its role in a vaccination strategy that has so far lagged behind those in Britain and the United States.</p><p>An internal document from the German health ministry dated Feb. 22, and a schedule published by the Italian health ministry on March 3, confirm that under the EU contract J&amp;J had committed to delivering around 55 million doses in the second quarter.</p><p>That includes about 10 million to Germany and 7.3 million to Italy. Supplies are expected to double in the third quarter, the two schedules show.</p><p>But J&amp;J has not yet provided figures on planned deliveries. “We don’t really know how much to expect,” the EU official said.</p><p><b>LATER START</b></p><p>Dutch Health Minister Hugo de Jonge told reporters he expected the company, which produces its COVID-19 vaccines for the EU in the Netherlands, to meet its second-quarter target of about three million doses for the country, although with limited deliveries in April and a ramp-up later in the quarter.</p><p>Ireland also expects J&amp;J to begin supplies a bit later in April than initially planned, with the largest deliveries at the end of the second quarter, the head of the country’s health service operator said on Tuesday, confirming earlier estimates for supplies through June.</p><p>EU countries raised questions earlier in the year about J&amp;J’s production network and contract with the EU, which would require it to send vaccines made at its Dutch factory to the United States for bottling before being shipped back to the EU.</p><p>A second EU official, also involved in talks with vaccine makers, said the bloc was trying to boost industrial capacity to bottle more shots in the EU, as part of plans to smooth out J&amp;J deliveries.</p><p>Actual deliveries have often diverged from contractual obligations as vaccine makers have struggled to ship millions of shots at breakneck pace amid the pandemic.</p><p>AstraZeneca cut planned first-quarter deliveries of its vaccine to the EU to 40 million doses from 90 million, and told the bloc second-quarter supplies would be halved. It later said it was striving to provide more shots from outside Europe.</p><p>Pfizer/BioNTech and Moderna have also faced delays in their deliveries to the EU, but kept their targets for the first quarter.</p><p>Under the contract with J&amp;J, the EU has also the option of ordering another 200 million doses, which if exercised would double its supply from the U.S. firm.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>J&J 'under stress' to meet EU second-quarter vaccine supply goal - source</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJ&J 'under stress' to meet EU second-quarter vaccine supply goal - source\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-09 21:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Johnson &amp; Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its COVID-19 vaccine to the bloc in the second quarter of the year, an EU official told Reuters.</p><p>Any delay would be a further blow to EU’s vaccination plans, which have been hampered by bumpy supplies from other vaccine makers and a slow rollout of shots in many member states.</p><p>J&amp;J told the EU last week that issues with the supply of vaccine ingredients and equipment meant it was “under stress” to meet the goal of delivering 55 million doses by the end of June, the EU official - who is directly involved in confidential talks with the U.S. company - told Reuters on condition of anonymity.</p><p>The official added the company had said it was not impossible to meet the goal, but that it showed caution.</p><p>J&amp;J’s vaccine, which requires only one dose for protection, is expected to be approved on March 11 for use in the EU by the bloc’s regulator. EU officials have said deliveries could start in April.</p><p>The company has committed to deliver 200 million doses of its vaccine to the bloc this year.</p><p>“Aligned with our agreement, we expect to begin supplying our commitment of 200 million doses to the European Union in the second quarter of 2021,” J&amp;J said in a statement, declining to comment on possible delays or the second-quarter target.</p><p>J&amp;J began rolling out its vaccine in the United States this month, with a target of delivering 100 million doses by the end of May, but has nearly halved its delivery forecasts for March to 20 million doses as it ramps up new manufacturing facilities.</p><p>A spokesman for the European Commission declined to comment on J&amp;J’s delivery schedules. The Commission coordinates EU talks with vaccine makers and has come under fire for its role in a vaccination strategy that has so far lagged behind those in Britain and the United States.</p><p>An internal document from the German health ministry dated Feb. 22, and a schedule published by the Italian health ministry on March 3, confirm that under the EU contract J&amp;J had committed to delivering around 55 million doses in the second quarter.</p><p>That includes about 10 million to Germany and 7.3 million to Italy. Supplies are expected to double in the third quarter, the two schedules show.</p><p>But J&amp;J has not yet provided figures on planned deliveries. “We don’t really know how much to expect,” the EU official said.</p><p><b>LATER START</b></p><p>Dutch Health Minister Hugo de Jonge told reporters he expected the company, which produces its COVID-19 vaccines for the EU in the Netherlands, to meet its second-quarter target of about three million doses for the country, although with limited deliveries in April and a ramp-up later in the quarter.</p><p>Ireland also expects J&amp;J to begin supplies a bit later in April than initially planned, with the largest deliveries at the end of the second quarter, the head of the country’s health service operator said on Tuesday, confirming earlier estimates for supplies through June.</p><p>EU countries raised questions earlier in the year about J&amp;J’s production network and contract with the EU, which would require it to send vaccines made at its Dutch factory to the United States for bottling before being shipped back to the EU.</p><p>A second EU official, also involved in talks with vaccine makers, said the bloc was trying to boost industrial capacity to bottle more shots in the EU, as part of plans to smooth out J&amp;J deliveries.</p><p>Actual deliveries have often diverged from contractual obligations as vaccine makers have struggled to ship millions of shots at breakneck pace amid the pandemic.</p><p>AstraZeneca cut planned first-quarter deliveries of its vaccine to the EU to 40 million doses from 90 million, and told the bloc second-quarter supplies would be halved. It later said it was striving to provide more shots from outside Europe.</p><p>Pfizer/BioNTech and Moderna have also faced delays in their deliveries to the EU, but kept their targets for the first quarter.</p><p>Under the contract with J&amp;J, the EU has also the option of ordering another 200 million doses, which if exercised would double its supply from the U.S. firm.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"JNJ":"强生"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117128744","content_text":"Johnson & Johnson has told the European Union it is facing supply issues that may complicate plans to deliver 55 million doses of its COVID-19 vaccine to the bloc in the second quarter of the year, an EU official told Reuters.Any delay would be a further blow to EU’s vaccination plans, which have been hampered by bumpy supplies from other vaccine makers and a slow rollout of shots in many member states.J&J told the EU last week that issues with the supply of vaccine ingredients and equipment meant it was “under stress” to meet the goal of delivering 55 million doses by the end of June, the EU official - who is directly involved in confidential talks with the U.S. company - told Reuters on condition of anonymity.The official added the company had said it was not impossible to meet the goal, but that it showed caution.J&J’s vaccine, which requires only one dose for protection, is expected to be approved on March 11 for use in the EU by the bloc’s regulator. EU officials have said deliveries could start in April.The company has committed to deliver 200 million doses of its vaccine to the bloc this year.“Aligned with our agreement, we expect to begin supplying our commitment of 200 million doses to the European Union in the second quarter of 2021,” J&J said in a statement, declining to comment on possible delays or the second-quarter target.J&J began rolling out its vaccine in the United States this month, with a target of delivering 100 million doses by the end of May, but has nearly halved its delivery forecasts for March to 20 million doses as it ramps up new manufacturing facilities.A spokesman for the European Commission declined to comment on J&J’s delivery schedules. The Commission coordinates EU talks with vaccine makers and has come under fire for its role in a vaccination strategy that has so far lagged behind those in Britain and the United States.An internal document from the German health ministry dated Feb. 22, and a schedule published by the Italian health ministry on March 3, confirm that under the EU contract J&J had committed to delivering around 55 million doses in the second quarter.That includes about 10 million to Germany and 7.3 million to Italy. Supplies are expected to double in the third quarter, the two schedules show.But J&J has not yet provided figures on planned deliveries. “We don’t really know how much to expect,” the EU official said.LATER STARTDutch Health Minister Hugo de Jonge told reporters he expected the company, which produces its COVID-19 vaccines for the EU in the Netherlands, to meet its second-quarter target of about three million doses for the country, although with limited deliveries in April and a ramp-up later in the quarter.Ireland also expects J&J to begin supplies a bit later in April than initially planned, with the largest deliveries at the end of the second quarter, the head of the country’s health service operator said on Tuesday, confirming earlier estimates for supplies through June.EU countries raised questions earlier in the year about J&J’s production network and contract with the EU, which would require it to send vaccines made at its Dutch factory to the United States for bottling before being shipped back to the EU.A second EU official, also involved in talks with vaccine makers, said the bloc was trying to boost industrial capacity to bottle more shots in the EU, as part of plans to smooth out J&J deliveries.Actual deliveries have often diverged from contractual obligations as vaccine makers have struggled to ship millions of shots at breakneck pace amid the pandemic.AstraZeneca cut planned first-quarter deliveries of its vaccine to the EU to 40 million doses from 90 million, and told the bloc second-quarter supplies would be halved. It later said it was striving to provide more shots from outside Europe.Pfizer/BioNTech and Moderna have also faced delays in their deliveries to the EU, but kept their targets for the first quarter.Under the contract with J&J, the EU has also the option of ordering another 200 million doses, which if exercised would double its supply from the U.S. firm.","news_type":1},"isVote":1,"tweetType":1,"viewCount":116,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":126800775,"gmtCreate":1624549531097,"gmtModify":1703840196606,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SE\">$SEA LTD(SE)$</a>Not sure about you but I see a W pattern on the daily with an upside target of around usd400. Might dip back to the usd200++ level if it fails.Sea Group looking bullish but they should lookto&nbsp;sustain&nbsp;growth.Not here to predict but to prepare.*my opinion, never financial advice*","listText":"<a href=\"https://laohu8.com/S/SE\">$SEA LTD(SE)$</a>Not sure about you but I see a W pattern on the daily with an upside target of around usd400. Might dip back to the usd200++ level if it fails.Sea Group looking bullish but they should lookto&nbsp;sustain&nbsp;growth.Not here to predict but to prepare.*my opinion, never financial advice*","text":"$SEA LTD(SE)$Not sure about you but I see a W pattern on the daily with an upside target of around usd400. Might dip back to the usd200++ level if it fails.Sea Group looking bullish but they should lookto sustain growth.Not here to predict but to prepare.*my opinion, never financial advice*","images":[{"img":"https://static.tigerbbs.com/d3e90c1fec4c1674412f816421694e72","width":"1170","height":"2532"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/126800775","isVote":1,"tweetType":1,"viewCount":1406,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},{"id":323596515,"gmtCreate":1615352128437,"gmtModify":1704781549665,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"It can bounce but I hope it maintains the bounce&nbsp;","listText":"It can bounce but I hope it maintains the bounce&nbsp;","text":"It can bounce but I hope it maintains the bounce","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/323596515","repostId":"1140398434","repostType":4,"repost":{"id":"1140398434","pubTimestamp":1615349081,"share":"https://ttm.financial/m/news/1140398434?lang=&edition=fundamental","pubTime":"2021-03-10 12:04","market":"us","language":"en","title":"Tech bounces back — Here's what analysts say investors should watch","url":"https://stock-news.laohu8.com/highlight/detail?id=1140398434","media":"cnbc","summary":"Tech stocks led a market rallyon Tuesday asbond yields declined.\nThe tech-heavyNasdaq 100rallied mor","content":"<div>\n<p>Tech stocks led a market rallyon Tuesday asbond yields declined.\nThe tech-heavyNasdaq 100rallied more than 4% in its best day since early November.\nHere's what market experts said about the move.\nMike...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/09/tech-stocks-bounce-back-what-experts-say-investors-should-watch.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tech bounces back — Here's what analysts say investors should watch</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTech bounces back — Here's what analysts say investors should watch\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-10 12:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/03/09/tech-stocks-bounce-back-what-experts-say-investors-should-watch.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tech stocks led a market rallyon Tuesday asbond yields declined.\nThe tech-heavyNasdaq 100rallied more than 4% in its best day since early November.\nHere's what market experts said about the move.\nMike...</p>\n\n<a href=\"https://www.cnbc.com/2021/03/09/tech-stocks-bounce-back-what-experts-say-investors-should-watch.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite"},"source_url":"https://www.cnbc.com/2021/03/09/tech-stocks-bounce-back-what-experts-say-investors-should-watch.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1140398434","content_text":"Tech stocks led a market rallyon Tuesday asbond yields declined.\nThe tech-heavyNasdaq 100rallied more than 4% in its best day since early November.\nHere's what market experts said about the move.\nMike Wilson, chief investment officer at Morgan Stanley, said recent weakness afflicted highly valued stocks, not just tech.\n\"It's not tech per se. It's expensive stocks, and some of those happen to be in the tech bucket. There's also expensive stocks in biotech, and there's expensive stocks even in nontech groups. And what's really changed in the last two or three months is that the bond market has woken up to the idea that actually the back end is going to move out, and so the narrative three months ago was that 'rates can't go up, they won't go up, the Fed won't let it happen.' But here we are, 1.5%, 1.6% [for the 10-year]. And so now the equity market is accepting this idea that it was inevitable. And we're adjusting. So I don't think this is the end of the bull market or the end of tech stocks per se, but it was an adjustment that was very necessary.\"\nDavid Kostin, chief U.S. equity strategist at Goldman Sachs, said tech is still a longer-term bet.\n\"The issue really is what's happening on the margin. We have huge fiscal stimulus coming, likely to be signed in the next day or so. We're likely to have very significant improvement in the vaccination process, more than 2 million people a day. So those things are about nearer-term activity, and that really does benefit an improvement of business fundamentals for some of the near-term, more cyclical-related stocks in the recovery trade, if you will. So if you want to think about longer term, sure, technology, secular growth, those are definitely tapping into some of the evolutions in what's happening in the economy, but near term, tactically it's likely to be cyclical.\"\nJim Grant, founder and editor of Grant's Interest Rate Observer, broke down the bond market.\n\"We have been in a 40-year bull market in bonds. Almost no one living on Wall Street today has any recollection of interest rates rising. We are predisposed to assume that rates go down, that seems natural. ... They are remarkably low when adjusted for inflation. As measured since 1962, as a saver, you'd get over 2.5 almost percentage points of real inflation-adjusted yield by owning the 10-year Treasury. Today you get exactly no real interest. ... So the value proposition for the 10-year Treasury, to me, is absolutely barren. There's nothing to be said as an investment for them.\"\nGabriela Santos, global market strategist at JPMorgan Asset Management, said it all comes back to earnings.\n\"I think one of the points we make is we're coming into this year with a much better outlook but with stretched valuations. So returns this year are really going to come from the change in earnings, and it's really the cyclical parts of the market that will see the biggest delta in earnings this year versus last year. Those are the kind of sectors that can absorb rising yields, that can really tap into this improvement in the economy. So just an example, financials will see a 40 percentage-point change in earnings, consumer discretionary 70 percentage points. If we look at health care, only 2 percentage points. Tech only 10%. So that's the reason why these rising bond yields related to rising growth benefits these more cyclical parts of the market.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":325047787,"gmtCreate":1615854124149,"gmtModify":1704787441210,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Go cathie!!","listText":"Go cathie!!","text":"Go cathie!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325047787","repostId":"1170973847","repostType":4,"repost":{"id":"1170973847","pubTimestamp":1615823072,"share":"https://ttm.financial/m/news/1170973847?lang=&edition=fundamental","pubTime":"2021-03-15 23:44","market":"us","language":"en","title":"Cathie Wood and ARK Invest see record volumes traded in ETFs","url":"https://stock-news.laohu8.com/highlight/detail?id=1170973847","media":"seekingalpha","summary":"Cathie Wood and ARK Invest see record trade volumes in their five actively managed exchange traded f","content":"<p>Cathie Wood and ARK Invest see record trade volumes in their five actively managed exchange traded funds.</p>\n<p>The five exchange traded funds ARKK, ARKQ, ARKW, ARKG, and ARKF have seen nearly $150b in volume this year. This amount is almost double what was traded in 2020 and nearly 25X what was traded in 2019.</p>\n<p>ARK Innovation ETF(NYSEARCA:ARKK)&nbsp;which closed&nbsp;+3.28%&nbsp;last week is&nbsp;+1.29%&nbsp;today and has turned over $78.262b in traded value so far in 2021.</p>\n<p>Autonomous Technology &amp; Robotics ETF(BATS:ARKQ)&nbsp;which closed&nbsp;+7.56%&nbsp;last week is&nbsp;+1.23%&nbsp;today and has turned over&nbsp;$8.241b&nbsp;in traded value so far in 2021.</p>\n<p>Next Generation Internet ETF&nbsp;(NYSEARCA:ARKW)&nbsp;which closed&nbsp;+8.49%&nbsp;last week is&nbsp;+1.36%&nbsp;today and has turned over&nbsp;$17.615b&nbsp;in traded value so far in 2021.</p>\n<p>Genomic Revolution ETF&nbsp;(BATS:ARKG)&nbsp;which closed&nbsp;+8.59%&nbsp;last week is&nbsp;+1.44%&nbsp;today and has turned over&nbsp;$31.428b&nbsp;in traded value so far in 2021.</p>\n<p>Fintech Innovation ETF&nbsp;(NYSEARCA:ARKF)&nbsp;which closed&nbsp;+7.49%&nbsp;last week is&nbsp;+0.70%&nbsp;today and has turned over&nbsp;$10.501b&nbsp;in traded value so far in 2021.</p>\n<li><p>Cathie Wood and Ark Invest have seen recordinflowsandoutflowsbut one thing that remains consistent is the record volumes investors have seen with the five actively managed ETFs.</p></li>\n<li><p>Cathie Wood and her innovative ETFs have been sensitive to rising bond yields as technology stocks have suffered the most in recent days.</p></li>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood and ARK Invest see record volumes traded in ETFs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood and ARK Invest see record volumes traded in ETFs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-15 23:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/3672689-cathie-wood-and-ark-invest-see-record-volumes-traded-in-etfs><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood and ARK Invest see record trade volumes in their five actively managed exchange traded funds.\nThe five exchange traded funds ARKK, ARKQ, ARKW, ARKG, and ARKF have seen nearly $150b in ...</p>\n\n<a href=\"https://seekingalpha.com/news/3672689-cathie-wood-and-ark-invest-see-record-volumes-traded-in-etfs\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ARKG":"ARK Genomic Revolution ETF","ARKK":"ARK Innovation ETF","ARKF":"ARK Fintech Innovation ETF","ARKQ":"ARK Autonomous Technology & Robotics ETF","ARKW":"ARK Next Generation Internation ETF"},"source_url":"https://seekingalpha.com/news/3672689-cathie-wood-and-ark-invest-see-record-volumes-traded-in-etfs","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170973847","content_text":"Cathie Wood and ARK Invest see record trade volumes in their five actively managed exchange traded funds.\nThe five exchange traded funds ARKK, ARKQ, ARKW, ARKG, and ARKF have seen nearly $150b in volume this year. This amount is almost double what was traded in 2020 and nearly 25X what was traded in 2019.\nARK Innovation ETF(NYSEARCA:ARKK) which closed +3.28% last week is +1.29% today and has turned over $78.262b in traded value so far in 2021.\nAutonomous Technology & Robotics ETF(BATS:ARKQ) which closed +7.56% last week is +1.23% today and has turned over $8.241b in traded value so far in 2021.\nNext Generation Internet ETF (NYSEARCA:ARKW) which closed +8.49% last week is +1.36% today and has turned over $17.615b in traded value so far in 2021.\nGenomic Revolution ETF (BATS:ARKG) which closed +8.59% last week is +1.44% today and has turned over $31.428b in traded value so far in 2021.\nFintech Innovation ETF (NYSEARCA:ARKF) which closed +7.49% last week is +0.70% today and has turned over $10.501b in traded value so far in 2021.\nCathie Wood and Ark Invest have seen recordinflowsandoutflowsbut one thing that remains consistent is the record volumes investors have seen with the five actively managed ETFs.\nCathie Wood and her innovative ETFs have been sensitive to rising bond yields as technology stocks have suffered the most in recent days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":212,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":325047668,"gmtCreate":1615854105854,"gmtModify":1704787441371,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Please be safe!","listText":"Please be safe!","text":"Please be safe!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/325047668","repostId":"1145894014","repostType":4,"isVote":1,"tweetType":1,"viewCount":225,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":322670070,"gmtCreate":1615806244890,"gmtModify":1704786767884,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Appreciate posts like this that end up on Tiger’s news page. It helps us do due diligence easily&nbsp;","listText":"Appreciate posts like this that end up on Tiger’s news page. It helps us do due diligence easily&nbsp;","text":"Appreciate posts like this that end up on Tiger’s news page. It helps us do due diligence easily","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/322670070","repostId":"1164885443","repostType":4,"isVote":1,"tweetType":1,"viewCount":163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":323739389,"gmtCreate":1615373716141,"gmtModify":1704781828067,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"This is good news but I hope it sustains the bounce","listText":"This is good news but I hope it sustains the bounce","text":"This is good news but I hope it sustains the bounce","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/323739389","repostId":"2117431698","repostType":2,"repost":{"id":"2117431698","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1615209330,"share":"https://ttm.financial/m/news/2117431698?lang=&edition=fundamental","pubTime":"2021-03-08 21:15","market":"us","language":"en","title":"BRIEF-Ayro Inc - Launch Of Electric Vaccine Vehicle","url":"https://stock-news.laohu8.com/highlight/detail?id=2117431698","media":"Reuters","summary":"March 8 (Reuters) - AYRO Inc   :   * AYRO INC - LAUNCH OF ELECTRIC VACCINE VEHICLESource text for Ei","content":"<html><body><p>March 8 (Reuters) - AYRO Inc   :</p><p>   * AYRO INC - LAUNCH OF ELECTRIC VACCINE VEHICLE</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Ayro Inc - Launch Of Electric Vaccine Vehicle</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Ayro Inc - Launch Of Electric Vaccine Vehicle\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-03-08 21:15</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>March 8 (Reuters) - AYRO Inc   :</p><p>   * AYRO INC - LAUNCH OF ELECTRIC VACCINE VEHICLE</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CGEM":"Cullinan Therapeutics","APR":"Apria, Inc.","AYRO":"AYRO, Inc.","SANA":"Sana Biotechnology, Inc.","LHDX":"Lucira Health, Inc.","LABP":"Landos Biopharma, Inc."},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2117431698","content_text":"March 8 (Reuters) - AYRO Inc   :   * AYRO INC - LAUNCH OF ELECTRIC VACCINE VEHICLESource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":157,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":320265056,"gmtCreate":1615119214675,"gmtModify":1704778770806,"author":{"id":"3578051801807213","authorId":"3578051801807213","name":"Fishingboy","avatar":"https://static.tigerbbs.com/f0ff6d321e13a5a7b419cda3219c1b1f","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3578051801807213","authorIdStr":"3578051801807213"},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/320265056","repostId":"1169596583","repostType":4,"repost":{"id":"1169596583","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1614958557,"share":"https://ttm.financial/m/news/1169596583?lang=&edition=fundamental","pubTime":"2021-03-05 23:35","market":"us","language":"en","title":"Palantir plunged more than 13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1169596583","media":"老虎资讯综合","summary":"(March 5)&nbsp;Palantir plunged more than 13%.","content":"<p>(March 5)&nbsp;Palantir plunged more than 13%.</p><p><img src=\"https://static.tigerbbs.com/13f756ec57cca85c31b6be070941d7c1\" tg-width=\"1059\" tg-height=\"499\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir plunged more than 13%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir plunged more than 13%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-03-05 23:35</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>(March 5)&nbsp;Palantir plunged more than 13%.</p><p><img src=\"https://static.tigerbbs.com/13f756ec57cca85c31b6be070941d7c1\" tg-width=\"1059\" tg-height=\"499\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169596583","content_text":"(March 5) Palantir plunged more than 13%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":58,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}